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Enantioselective (Formal) Aza-Diels-Alder Reactions with Danishefsky’s Diene and Non-
Danishefsky Type Dienes 
Sharon K. Lee 
Highly functionalized piperidines represent an important class of heterocycles that are 
found in natural products and medicinally active agents. As a direct result, efforts to develop 
enantioselective diene-imine (aza-Diels-Alder) reactions to efficiently access these substructures 
have increased.   We have developed highly enantioselective silicon Lewis acid mediated formal 
aza-Diels-Alder reactions with Danishefsky’s diene and non-Danishefsky’s dienes to generate 
these biologically important heterocycles.  To further prove the power of this method to access 
complex piperidine structures, we have accomplished the efficient enantioselective synthesis of 
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Chapter 1: Hypervalent Silicon as a Lewis Acid  
1.1 Introduction 
There is no doubt Lewis acid promoted reactions have made a large impact on synthetic 
organic chemistry.   However, this class of reactions suffers from many limitations.  Often times, 
toxic and expensive metals are used along with high molecular weight and expensive chiral 
ligands.  Many reactions employing Lewis acids require precise cryogenic temperature control to 
prevent unwanted side reactions.  These limitations restrict the use of many Lewis acid promoted 
reactions in the pharmaceutical industry, which utilizes large-scale chemical reactions.   In order 
to address these limitations, the Leighton group has sought to develop a mild, inexpensive and 
readily available chiral Lewis acid.   Silicon was found to fit the bill on all accounts mainly due 
to two important concepts:  Lewis base activation and strain release Lewis acidity.  This chapter 
will provide a brief overview of the genesis of both concepts and the Leighton group’s 
application of these concepts to the development of novel chiral silicon Lewis acid reagents.  The 
background information discussed in this chapter will then set the stage for a discussion about 
our interesting discoveries in silicon Lewis acid promoted aza-Diels-Alder reactions. 
1.2 Lewis base activation of silicon Lewis acids 
The addition of a Lewis base to a Lewis acid results in an acid-base adduct with an electron 




increased electrophilicity of a silicon Lewis acid upon addition of a Lewis base.1  Increased 
electrophilicity is observed due to two main principles: changes in intramolecular charge 
distribution and the expansion of silicon’s coordination sphere.  As shown in Scheme 1.1, the 
addition of a Lewis base 1.1 to tetracoordinate silicon 1.2 results in an increased positive charge 
on the resulting hypervalent silicon species 1.3. In support of this theory, Mulliken charges at the 
silicon atom in the series SiF4, SiF5-, and SiF62- were found to be +1.19, +1.14, and +2.12 
respectively. 2   
Scheme 1.1 Lewis acid-base complexation 
 
 As mentioned previously, the expansion of silicon’s coordination sphere also greatly 
improves its Lewis acidity.  This phenomenon is due to silicon’s ability to readily access its 3p 
orbital that engages in an electron-rich three center four-electron bond.1 This concept can be 
examined through molecular orbital theory as shown in Figure 1.1.  The silicon 3p orbital 
engages two σ orbitals from two chlorine atoms.  This results in the formation of a HOMO 
(highest occupied molecular orbital) that contains a central silicon atom with more electron 
deficient character due to the presence of a node from the 3p orbital.  In addition, the electron 
                                                 
1 Denmark, S. E.; Beutner, G. L.  Angew. Chem. Int. Ed. 2008, 47(9), 1560-1638. 




density on the peripheral atoms is increased due to higher electron density on the periphery of the 
mixed 3p orbital.   
Figure 1.1 Molecular orbital diagram of a three center four-electron complex 
 
This concept of Lewis base activation has made a significant impact on organic chemistry 
and has been applied to many different types of reactions to date.3  For example, the Sakurai 
group was able to treat otherwise inert allyltrifluorosilane with cesium fluoride to form a 
competent allylating reagent that was capable of reacting with different types of carbonyl 
compounds.4  In further support of a fluoride activated hypervalent silicon complex, (E)- and 
(Z)- crotyl reagents (1.4 and 1.7, Scheme 1.2) reacted with benzaldehyde in the presence of CsF 
to form 1.6 and 1.9 with high and divergent diastereoselectivity.5  This selectivity can be 
explained through highly organized chair conformations in the hypervalent silicon transition 
states 1.5 and 1.8.    
                                                 
3 Orito, Y.; Nakajima, M. Synthesis. 2006, 9, 1391 -1401. 
4 Hosami, H.; Shirahata, S.; Sakurai, H. Tetrahedron Lett. 1978, 33, 3043-3046. 





Scheme 1.2 CsF promoted crotylations 
 
1.3 Strain release Lewis acidity 
In addition to Lewis base activated silicon Lewis acids, ligands which form strained rings 
with silicon in a tetrahedral complex can promote rearrangement of silicon into a trigonal 
bipyramidal complex upon addition of a nucleophile.  This phenomenon was first investigated by 
Westheimer in 1967 with five membered cyclic phosphates.6  As shown in Figure 1.2, a 
tetrahedral configuration of X-Si-Y would prefer a bond angle of 109.5°.  However, since X-Si-
Y is part of a five membered ring, a bond angle of only about 90° is allowed.  A rehybridization 
to a trigonal bipyramidal complex upon addition of a nucleophile better accommodates a 90° 
bond angle by allowing the substituents on the ring to occupy an equatorial and an apical 
position.  This desire to rehybridize decreases the activation energy for the coordination of a 
nucleophile, which in turn, increases Lewis acidity.   Previous work by Utimoto demonstrates 
this remarkable phenomenon as shown in Figure 1.3.7  It was found that allylation of 
benzaldehyde was unsuccessful with allyldimethylphenylsilane.  However, an increase in 
                                                 
6 Westheimer, F. H. Acc. Chem. Res. 1968, 1, 70-78.  




reactivity occurred upon use of a strained silacyclobutane.  In addition to Utimoto, the Myers and 
Denmark groups have utilized strained silacyclobutanes to form different types of C-C bonds.8  
Figure 1.2 Strain release Lewis acidity 
 
Figure 1.3 Utimoto’s strain release Lewis acidity in the allylation of benzaldehyde 
 
1.4 Chiral silicon mediated allylations 
Due to enhanced activity of silicon through the simple concepts of Lewis base activation 
and strain release Lewis acidity, many groups have become interested in silicon mediated 
enantioselective allylations.9   The Kira group pioneered the use of five-membered silacycles 
(1.10, Scheme 1.3) with a chiral tartrate backbone to allylate benzaldehyde and generate chiral 
alcohols 1.11 in moderate yield and low enantioselectivity.10   
                                                 
8 a) Myers, A. G.; Kephart, S. E.; Chen, H. J. Am. Chem. Soc. 1992, 114, 7922-7923. b) Denmark, S.; 
Griedal, B. D.; Coe, D. M.; Schnute, M.E. J. Am. Chem. Soc. 1994, 116, 7026-7043. 
9 Fleming, I.; Barbero, A.; Walter, D. Chem. Rev. 1997, 97, 2063-2192. 





Scheme 1.3 Silicon mediated enantioselective allylation 
 
1.5 Leighton group discovery of a highly efficient chiral silicon reagent  
In order to address low enantioselectivities and moderate yields of silicon Lewis acid 
promoted allylations, the Leighton group began investigating the preparation of a readily 
synthesized and cost effective chiral silicon Lewis acid.11  The importance of ring strain became 
obvious after initial screens of silicon Lewis acids shown in Table 1.1. Entries 1-3 indicated 
relatively unstrained silanes 1.12-1.14 gave no product with benzaldehyde.  However, when 
strained silacycle 1.15 was utilized, the desired product was formed with a yield of 52%. 
                                                 





Table 1.1  Allylation reagent screen 
 

















It will also be noted that the ease of preparation of each silicon reagent from commercially 
available and cheap starting materials allowed for an efficient screen of silicon Lewis acids.  For 
example commercially available allyltrichlorosilane and pinacol react to form silicon Lewis acid 




Scheme 1.4 Synthesis of silicon Lewis acids 
 
In light of the enhanced activity of a five-membered silacycle and the ease of its synthesis, 
the Leighton group set out to identify a chiral silicon Lewis acid version of 1.15. After 
optimization and screening of commercially available chiral backbones, it was found chiral 
reagent 1.16 in Scheme 1.5 could mediate the allylation of a range of aldehyde products in good 
yields and excellent enantioselectivities.11 In addition, the chiral pseudoephedrine backbone is a 
relatively cheap and readily available small molecular weight chiral ligand.  As shown in 
Scheme 1.6, the synthesis of 1.16 in 92% yield with a dr of 2:1 is accomplished easily upon 
addition of pseudoephedrine to allyltrichlorosilane. 
Scheme 1.5 Leighton group chiral allyl silicon reagent 
 
Scheme 1.6 Synthesis of the Leighton pseudoephedrine-derived allylation reagent 
 
A subsequent report by the Leighton group indicated that chiral diamine derived reagent 
(1.17, Figure 1.4) could improve enantioselectivities and expand the substrate scope.12  In 
                                                 




addition, analogous crotylation reagents 1.18 and 1.19 were found to react with aldehydes in 
high enantioselectivities and yield.13 The group was able to further demonstrate the utility of this 
method in the total syntheses of (+)-SCH 351448 and dolabelide D.14    
Figure 1.4 Chiral diamine derived reagents 
 
With a general method to allylate aldehydes in hand, the Leighton group sought to allylate 
imines as well.  Although many different imine analogous were investigated, only 
acylhydrazones could be successfully allylated. As shown in Scheme 1.7, silane 1.16 facilitated 
allylation of acylhydrazones in excellent yields and enantioselectivities.   
Scheme 1.7 Allylation of acylhydrazones 
 
Crotylation reactions were also achieved in high selectivity with (E)- and (Z)- crotyl silanes 
(1.20 and 1.24, Scheme 1.8) giving the corresponding syn- and anti- hydrazides 1.22 and 1.25.  
Transition states 1.23 and 1.26 were invoked to explain the stereoselectivity observed.  These 
hexacoordinate silicon transition states were also supported by similar Lewis base activated 
                                                 
13 Hackman, B. M; Lombardi, P. J.; Leighton, J. L. Org. Lett. 2004, 5(23), 4375-4377. 
14 a) Bolshakov, S.; Leighton, J. L. Org. Lett. 2005, 7(17), 3809-3812. b) Park, P. K.; O'Malley, S. J.; Schmidt, D. 




allylations.15  As shown, both transition states 1.23 and 1.26 involve a two-point binding/double 
activation of silane through the Lewis basic imine nitrogen and acyl oxygen of the hydrazone.   
Scheme 1.8 Crotylation of hydrazones and proposed transition states 
                                                 





The scope of this reaction was also extended to the allylation of ketone derived hydrazone 
substrates as shown in Table 1.2.16  Aliphatic as well as aryl ketone derived hydrazones were 
well tolerated with excellent yields and enantioselectivity.  Dialiphatic ketone derived hydrazone 
substrates (Entries 7-8) were also tolerated.  In addition, excellent yields and enantioselectivity 
were achieved from a sterically hindered hydrazone (Entry 3).  Another advantage of this 
allylation procedure is its ability to overcome previous challenges associated with E:Z mixtures 
of hydrazones.   For example, only E isomer of the hydrazone was used in Entry 8 and compared 
with Entry 9 in which the hydrazone starting material was used as a 3.8:1 mixture of the E:Z 
isomers.  Similar yields and enantioselectivities were obtained for Entries 8 and 9, and yields of 
over 80% further indicated a mechanism that invoked E:Z isomerization.  
 
                                                 




Table 1.2 Allylation of ketone derived acylhydrazones 
 
Entry R R1 Yield (%) ee (%) 
1 Ph Me 86 88 
2 Ph CO2Me 76 85 
3 Ph i-Pr 80 85 
4 p-MeO-C6H4 Me 70 86 
5 thien-2-yl Me 70 88 
6 BOCN-indol-3-yl Me 64 89 
7 c-hex Me 78 94 
8 PhCH2CH2 
(E only) 
Me 86 83 
9 PhCH2CH2 
(E:Z, 3.8:1) 
Me 87 97 
 
In order to further investigate the interaction of the hydrazone and silicon Lewis acid, a 
number of experiments were conducted as shown in Scheme 1.9.   When methoxy silane 1.27 
was subjected to similar reaction conditions as silane 1.16, complete loss of reactivity was 
observed.   In addition, hydrazone 1.28 was substituted with methylated hydrazone 1.29, which 
again resulted in complete loss of reactivity.   These results taken together warranted a re-
examination of previously proposed transition states 1.23 and 1.26.  The inactivity of 1.27 
indicated the significance of a good leaving group on silicon.  In addition, the inactivity of 1.29 




support and explanation of these hypotheses was obtained when hydrazone 1.31 and silane 1.30 
shown in Scheme 1.10 were mixed in toluene.  Initial 1H NMR analysis of a white precipitate 
obtained in 90% yield showed a single complex had formed.  Importantly, a doublet for the N-
Me signal indicated protonation of this nitrogen had occurred.  In fact, re-crystallization of this 
material yielded x-ray quality crystals 1.33 to reveal hydrazone 1.31 and silane 1.30  converged 
into complex 1.32. 






Scheme 1.10 Crystal structure of hydrazone-silane complex 
 
There are a few important features to note for complex 1.32.  First, the hypothesis that the 
(E)- hydrazone isomerizes to the (Z)- hydrazone is supported.  In addition, a pentacoordinated 
silicon center in which the chloride is displaced by the acyl oxygen of the hydrazone is shown, 
indicating the importance of a ligand on silicon with good leaving group properties.   This 
pentacoordinated or trigonal bipyramidal silicon also indicates a preference for rearrangement of 
a five-membered silacycle 1.30 from a tetrahedral configuration to a trigonal bipyramidal 
configuration in the presence of a nucleophile.  As mentioned previously, the drive for this 
rearrangment increases the Lewis acidity of the silicon center.  Lewis acidity is also increased 
through the protonation of the amine backbone from the acidic hydrogen on the acyl oxygen 




has been documented previously by Corey through his work with oxazaborolidine chemistry.17  
Based on crystal structure 1.33, the mechanistic model for the allylation of hydrazones was 
revised.  This model proposes hydrazone binding to allyl silane through the displacement of a 
chloride ion by the acyl oxygen of the hydrazone and the protonation of the pseudoephedrine 
backbone to form a highly Lewis acidic trigonal bipyramidal silane complex.  
The elucidation of this silane-hydrazone complex has inspired the development of different 
Leighton silicon reagents for many different types of organic transformations.18  As shown in 
Figure 1.5, reactivity of Leighton silicon Lewis acids can be easily tuned through the 
manipulation of the R group on silicon.   In addition, many different types of nucleophiles can be 
added to the hydrazone-silicon complex.    
Figure 1.5 General use of Leighton silane reagents 
 
Representative examples of recent applications of the Leighton group hydrazone-silicon 
complex are shown in Figure 1.6. Stereochemical induction can be explained through the 
addition of the nucleophile away from the sterically hindered R group on the silicon as shown in 
Figure 1.5.    
                                                 
17 Corey, E. J.; Shibata, T.; Lee, T. W. J. Am. Chem. Soc. 2002, 124, 3808-3809. 
18 a) Shirakawa, S.; Lombardi, P. J.; Leighton, J. L. J. Am. Chem. Soc. 2005, 127, 9974-9975 b) Notte, T. G.; 
Leighton, J. L. J. Am. Chem. Soc. 2008, 130, 6676-6677. c) Notte, G. T.; Baxter Vu, J. M.; Leighton, J. L. Org. Lett 




Figure 1.6 Silicon mediated Friedel-Crafts and Mannich reactions 
 
1.6 Conclusion 
Two general concepts of silicon Lewis acid activation were discussed: Lewis base 
activation and strain release Lewis acidity.   With these concepts as a basis for the rational design 
of a reactive silicon Lewis acid, many groups have contributed to the field of silicon mediated 
reactions.  The Leighton group has contributed significantly to this field through the discovery of 
novel chiral silicon reagents that are readily prepared and highly efficient in many different types 
of synthetic transformations.  The next two chapters will discuss my contribution to silicon 
mediated aza-Diels-Alder reactions and its application to the total synthesis of the drug target 
casopitant.    
 
Chapter 2:  Aza-Diels Alder Reactions with Danishefsky’s Diene 
2.1 Introduction 
Highly functionalized piperidines represent an important class of heterocycles that are 
found in natural products and medicinally active agents as shown in Figure 2.1. For example, 




nausea.19 The complex natural product daphnioldhanine J is being investigated as an agent 
against platelet aggregation.20   Swainsonine is another natural product with potential as a drug 
for gastric carcinoma.21  
Figure 2.1 Piperidines as important heterocycles 
 
Aza-Diels-Alder reactions are one of the most efficient ways to access these important 
heterocycles.  As a direct result, efforts to develop enantioselective aza-Diels-Alder reactions to 
efficiently access these substructures have increased.22  As shown in Figure 2.2, aza-Diels-Alder 
reactions involve a [4+2] cyclization between a diene and imine to form functionalized 
piperidine products.  
                                                 
19 Alvaro, G.; Di Fabio, R.; Maragni, P.; Tampieri, M.; Tranquillini, M. E.;  PCT Int.  Appl.  (2002), 
WO0232867. 
20 Mu, S-Z.; Wang, J-S, Yang, X-S.; He, H-P.; Li, C-S.; Di, Y-T.; Wang, Y.; Zhang, Yu.; Fang, X.; Huang, 
L-J.; Hao, X-J. J. Nat. Prod. 2008, 71, 564-569. 
21  B. Lindsay, S. G.; Pyne, J. Org.  Chem. 2002, 67, 7774-7780. 
22 See reviews: (a) Jørgensen, K. A. Angew. Chem. Int. Ed. 2000, 39, 3558-3588; (b) Kobayashi, S. In 
Cycloaddition Reactions in Organic Synthesis; Kobayashi, S., Jørgensen, K. A., Eds.; Wiley-VCH: Weinheim, 




Figure 2.2 General aza-Diels-Alder reactions 
 
In particular, aza-Diels-Alder reactions with Danishefsky’s diene have been studied 
extensively due to the readily available diene and potential to efficiently access highly 
substituted piperidines (Figure 2.2).21 Although impressive successes have been reported, 
substrate generality is limited.  Only a few research groups have accessed both aryl and aliphatic 
aldimines in aza-Diels-Alder reactions.   These methods often require harsh conditions for the 
removal of the N-activation group to reveal the unprotected pyridinone products.  For example, 
Hoveyda’s silver catalyzed aza-Diels-Alder reactions utilized both aryl and aliphatic aldimines 
(Figure 2.3), but harsh oxidative conditions were needed to cleave the required nitrogen 
protecting group.23  In addition, no example of N-C bond cleavage was shown for the Diels-
Alder products derived from aliphatic derived aldimines.  
Figure 2.3 Hoveyda’s aza-Diels-Alder reactions 
                                                 





In order to address the problem of N-C bond cleavage, Kobayashi utilized readily 
cleavable acylhydrazones in his zirconium mediated aza-Diels-Alder reactions.24  However, the 
substrate scope was limited since only aliphatic derived hydrazones could be utilized as shown in 
Figure 2.4. 
Figure 2.4  Kobayashi’s aza-Diels-Alder reactions 
 
2.2 Leighton group’s chiral silicon reagent for aza-Diels-Alder reactions 
In order to address these important gaps in Danishefsky diene aza-Diels-Alder reactions, 
we looked to our arsenal of chiral silicon reagents.  Previously, neopentoxy silane [(R,R-2.1), 
                                                 




Scheme 2.1] was found to be an effective chiral Lewis acid for highly enantioselective Mannich 
reactions of both aliphatic and aryl derived hydrazones.4 Thus, it was hoped this success could be 
extended to aza-Diels-Alder reactions with Danishefsky’s diene as shown in Figure 2.5. 
Scheme 2.1 Silicon mediated Mannich reactions 
 
Figure 2.5 Chiral neopentoxy silane mediated aza-Diels-Alder reactions 
 
To this end, our studies began with benzaldehyde derived benzoylhydrazone (2.2, Scheme 
2.2) and Danishefsky’s diene.  Initial experiments by Dr. Nicholas Perl revealed that after an 
aqueous workup a substantial amount of un-cyclized Mannich product 2.3 had formed.  
 





 Based on a reported X-ray crystal structure of a similar silane-hydrazone complex,25 a 
stepwise mechanism in which an enantioselective Mannich reaction proceeding through 
intermediates (2.4, Scheme 2.3) and 2.5 followed by hydrolysis of 2.5 by an aqueous workup to 
afford 2.3 seemed reasonable.  The stereochemical induction observed could be explained by 
attack of the diene away from the sterically hindered backside of the silicon due to the bulky 
neopentyl group as shown in 2.4. 
                                                 




Scheme 2.3 Possible mechanistic pathway 
 
With this mechanistic hypothesis in mind, Dr. Perl reasoned an acidic workup could 
protonate the vinylogous ester and promote cyclization on 2.5.  Indeed, with the addition of 1 N 
HCl, we found significant improvement in enantioselectivity and yield (82%, 89% ee) of 
pyridinone product (2.6, Scheme 2.4).   





With optimal conditions identified, Dr. Uttam Tambar set out to examine the scope of the 
reaction with respect to the hydrazone (2.7, Table 2.1) and (S,S)-2.1.  A range of aromatic 
derived hydrazones participated smoothly in the reaction and led to good yields and 
enantioselectivities of the desired pyridinone products 2.8.   Electron withdrawing 2.7d and 2.7e 
and electron-donating substituents 2.7f on the aromatic ring as well as ortho substitution 2.7c 
were tolerated.  
Table 2.1 Substrate scope of neopentoxy silane promoted aza-Diels-Alder reactions 
 
Entry R Ar Yield (%) ee (%) 
1 Ph (a) Ph 82 89 
2 2-Naph (b) p-CF3 -C6H4 85 90 
3 1-Naph (c) Ph 58 87 
4 p-Br-C6H4 (d) Ph 72 89 
5 p-CF3 -C6H4 (e) Ph 77 90 
6 p-OMe -C6H4 (f) p-CF3 -C6H4 73 90 
7 i-PrCH2 (g) p-OMe -C6H4 33 45 
 
Initial experiments with aliphatic derived hydrazone 2.7g and toluene resulted in low 




found dichloromethane significantly improved enantioselectivity and yields (81%, 92% ee, 
Scheme 2.5) .  However, to our surprise, a solvent dependent reversal in absolute stereochemical 
induction was observed, and we obtained the product ent-2.8g.   
Scheme 2.5 Reversal in absolute stereochemical induction 
 
In order to investigate if this effect was unique to 2.7g, we investigated (S,S)-2.1 
facilitated reaction between Danishefsky’s diene and (2.2, Scheme 2.6) in dichloromethane.  We 
found ent-2.6 was produced, indicating this stereochemical switch was not an anomaly only 
associated with 2.7g.  
Scheme 2.6 Solvent dependent absolute stereochemical switch 
 
Although this phenomenon did not appear to be electrophile dependent, we thought this 
effect may be nucleophile dependent.  As mentioned previously, we proposed our aza-Diels-
Alder reactions proceeded first through a Mannich addition then an acid catalyzed Michael 
addition and cyclization.  Previous Mannich reactions had shown that (R,R)-2.1 and hydrazone 




common complex.4 It is important to note that we did not see this solvent dependent switch in 
stereochemistry in the Mannich reactions, indicating that this phenomenon may be nucleophile 
dependent. Efforts to address this solvent dependent switch in enantioselectivity are ongoing. 
Scheme 2.7  Stereochemical model for Mannich reactions 
 
2.3 Total synthesis of casopitant 
During the course of our aza-Diels-Alder studies, we became interested in 
GlaxoSmithKline’s drug target casopitant (Figure 2.6) due to its functionalized piperidine core 




Figure 2.6 Casopitant 
 
Only one previous synthesis of casopitant has been reported.25 In the key step, racemic 
compound (2.11, Scheme 2.8) is subjected to known chiral amine 2.12 to form readily separable 
diastereomers 2.13 and 2.14.26  Although a total yield of over 90% was achieved, only 
diastereomer 2.13 or 46% of the material could be utilized for the synthesis of casopitant. The 
other 46% or diastereomer 2.14 was discarded due to the undesired stereocenter on the 
pyridinone ring.  We hoped an enantioselective synthesis of casopitant in which this stereocenter 
is set in a stereocontrolled manner would decrease waste and increase cost efficiency.    
Scheme 2.8 Previous synthesis of casopitant 
 
                                                 





We hoped to extend our previously discussed method for aza-Diels-Alder reaction to the 
first enantioselective synthesis of casopitant through a silane (S,S)-2.1 mediated aza-Diels-Alder 
reaction between hydrazone 2.15 and Danishefsky’s diene to form 2.16 and insert the needed 
stereocenter in a controlled and efficient manner (Scheme 2.9). 
Scheme 2.9 Towards the total synthesis of casopitant 
 
We first investigated silane [(R,R)-2.1, Scheme 2.10] mediated aza-Diels-Alder reaction of 
hydrazone 2.15 with Danishefsky’s diene in toluene.  Surprisingly, although enantioselectivity 
was high, the yield was low.  After a solvent screen, we found silane (S,S)-2.1 in 
dichloromethane proceeded to yield 2.16 in excellent yield and enantioselectivity (82%, 84% ee) 




Scheme 2.10 Formation of casopitant’s core  
 
With highly functionalized pyridinone 2.16 in hand, we turned to our next stereochemical 
challenge of installing the piperazine moiety. We hoped to install the piperazine core through a 
one pot reductive amination and conjugate reduction.  First attempts provided (2.17, Scheme 
2.11) as a mixture of readily separable diastereomers with moderate diastereoselectivity (87%, 
2.3:1 dr).   Surprisingly, we discovered 2.17 was produced in nearly racemized quantities (<10% 
ee) even though 2.16 was used in 84% ee.  We postulated that trace amounts of acid could 
catalyze a retro-Mannich reaction of conjugate reduced intermediate 2.18 to intermediate 2.19 
and could be responsible for the observed racemization.  Gratifyingly, addition of 
diisopropylethylamine (DIPEA) prevented racemization and provided product 2.20 in 7:1 
diastereoselectivity and 54% isolated yield of the major diastereomer.  It will be noted that the 
use of DIPEA increased the diastereoselectivity of the tandem reductive amination/reduction 
significantly. Although one can argue that DIPEA somehow impacts the kinetic selectivity in this 




Scheme 2.11 Double reduction and racemization 
 
With our major diastereomer (2.20) in hand, we set out to obtain our free secondary 
amine through a N-N bond cleavage.  Gratifyingly, hydrazide reduction of the N-N bond 2.20 
(Scheme 2.12) with SmI2 and subsequent aqueous workup provided a mixture of cleaved product 
2.21 and the amide by-product as a crude mixture.  Due to the polarity of the cleaved product and 




Subjection of the crude mixture to known chiral amine 2.12 proceeded with full conversion to 
casopitant and its epimer.  Casopitant was then converted to the HCl salt 2.22 to compare with 
spectral data (1H NMR) and confirm the identity of our synthetic material.19  
 Scheme 2.12 N-N bond cleavage 
 
2.4 Conclusion 
In summary, we developed a novel aza-Diels-Alder reaction of both aryl and alkyl 
substituted readily cleavable acyhydrazones with Danishefsky’s diene.  In order to prove the 
utility of this method, we reported a brief and efficient stereocontrolled synthesis of the drug 
target casopitant in only four steps and two purifications.  An enantioselective silicon mediated 
aza-Diels-Alder provided the key stereocenter of casopitant, which in turn guided the 




also led to the discovery of stereochemical erosion due to an acid mediated retro-Mannich during 
the double reduction.  We were able solve this problem by using a base buffer.27   
2.5 Supporting information 
General Information.   All reactions were carried out under an atmosphere of nitrogen in 
flame- or oven-dried glassware with magnetic stirring unless otherwise indicated. High-pressure 
reactions were carried out in a Parr stainless steel pressure vessel equipped with a pressure 
gauge, gas inlet, pressure release valve, and a glass liner. Degassed solvents were purified by 
passage through an activated alumina column.  Silanes (S,S)-2.1 and (R,R)-2.1 were prepared by 
a previously reported method.28 4-Fluoro-2-methylbenzaldehyde, 1-acetylpiperazine, 20% 
Pd(OH)2/C, 2-napthalaldehyde, 1-napthalaldehyde, and 98% (R)-N,α-Dimethylbenzylamine  can 
be purchased from Aldrich. Chiral amine 2.12 can be prepared according to literature 
procedure.29 4-(trifluoromethyl)-benzhydrazide can be purchased from Aldrich, or it can be 
synthesized from either the methyl ester30 or the carboxylic acid31 according to literature 
procedure. 1H NMR spectra were recorded on a Bruker DPX-400 (400 MHz) spectrometer and 
are reported in ppm from CDCl3 internal standard (7.26 ppm), CD3OD internal standard (4.78 
ppm and 3.31 ppm), or (CD3)2SO internal standard (2.50 ppm). Data are reported as follows: (s = 
singlet, br s = broad singlet, br d = broad doublet, br t= broad triplet, d = doublet, t = triplet, q = 
quartet, quin = quintet, m = multiplet, dd = doublet of doublets, ddd = doublet of doublet of 
doublets, sept= septet; coupling constant(s) in Hz; integration). Proton decoupled 13C NMR 
spectra were recorded on a Bruker DPX-300 (75 MHz) and are reported in ppm from CDCl3 
                                                 
27 Lee, S. K.; Tambar, U. K.; Perl, N. R.; Leighton, J. L. Tetrahedron. 2010, 66, 4769-4774. 
28 Notte, G. T.; Leighton, J. L. J. Am. Chem. Soc. 2008, 130, 6676-6677. 
29 Hodges, R.;  Martin, J.; Hammil, N. A.; Houson, I. N.; PCT Int.  Appl. WO 2006067395. 
30 Li, Y.; Liu, J.; Zhang, H.; Yang, X.; Liu, Z. Bio Med. Chem Lett. 2006, 16, 2278-2282. 
31  Romine, J.L.; Martin, S.W.; Meanwell, N.A.; Gribkoff, V.K.; Boissard, C.G.; Dworetzky, S.I.; Natale, J.; Moon, 




internal standard (77.23 ppm), CD3OD internal standard (49.15 ppm), or (CD3)2SO internal 
standard (39.51 ppm). Infrared spectra were recorded on a Perkin Elmer Paragon 1000 FT-IR 
spectrometer. Optical rotations were recorded on a Jasco DIP-1000 digital polarimeter.    
2.5.1 General procedure for the preparation of hydrazone starting material 
 
 
   
N'-(naphthalen-2-ylmethylene)-4-(trifluoromethyl)benzohydrazide: To a solution of 2-
naphthalaldehyde (222 mg, 1.42 mmol) in ethanol (20 mL) was added 4-(trifluoromethyl)-
benzhydrazide (264 mg, 1.29 mmol).  The reaction mixture was stirred for five hours and 
filtered.  The collected solids were washed with hexanes to provide a white solid (394 mg, 89%). 
1H NMR (400 MHz, (CD3)2SO) δ 12.13 (s, 1H), 8.63 (s, 1 H), 8.18-8.14 (m, 3H), 8.04-7.93 (m, 
6H), 7.59-7.57 (m, 2H); 13C NMR (75 MHz, (CD3)2SO) δ 162.00, 148.51, 137.24, 133.81, 
132.82, 131.86, 131.52 (q, J = 32 Hz), 128.97, 128.58, 128.54, 128.35, 127.77, 127.21, 126.77, 
125.50 (q, J = 3 Hz), 123.87 (q, J = 271 Hz), 122.64; IR (thin film) 1655, 1645 cm-1; HRMS 





N'-(4-(trifluoromethyl)benzylidene)benzohydrazide:  After reaction and workup as in 
the general procedure above, the title compound was isolated as a white solid (80%).  1H NMR 
(400 MHz, (CD3)2SO) δ 12.04 (s, 1H), 8.54 (s, 1 H), 7.94 (br t, J = 8 Hz, 4H), 7.82 (br d, J = 8 
Hz, 2H), 7.61 (br t, J = 7 Hz, 1H), 7.54 (br t, J = 7 Hz, 2 H); 13C NMR (75 MHz, (CD3)2SO) δ 
163.36, 145.99, 138.31, 133.22, 131.87, 129.70 (q, J = 32 Hz), 128.46, 127.69, 127.61, 125.64 
(q, J = 3 Hz), 124.07 (q, J = 270 Hz); IR (thin film) 1656, 1646 cm-1; HRMS (FAB+) calc’d for 
C15H11F3N2O ([M+H]+): 293.3, found 293.2 ([M+H]+). 
 
N'-(4-methoxybenzylidene)-4-(trifluoromethyl)benzohydrazide:  After reaction and 
workup as in the general procedure above, the title compound was isolated as a white solid 
(83%).  1H NMR (400 MHz, (CD3)2SO) δ 11.90 (s, 1H), 8.41 (s, 1 H), 8.11 (d, J = 8 Hz, 2H), 
7.91 (d, J = 8 Hz, 2H), 7.70 (d, J = 9 Hz, 2H), 7.04 (d, J = 8 Hz, 2 H); 13C NMR (75 MHz, 
(CD3)2SO) δ 161.76, 161.00, 148.50, 137.39, 131.42 (q, J =32 Hz), 128.83,128.50, 126.67, 
125.44 (q, J =3 Hz), 123.90 (q, J = 271 Hz), 114.37, 55.30; IR (thin film) 1665, 1603 cm-1; 
HRMS (FAB+) calc’d for C16H13F3N2O2 ([M+H]+): 323.3, found 323.2 ([M+H]+). 
 
4-methoxy-N'-(3-methylbutylidene)benzohydrazide: After reaction and workup as in the 
general procedure above, the title compound was isolated as a white solid (70%). 1H NMR (400 




(s, 3H), 2.14 (t, J = 6 Hz, 2H), 1.84 (sept, J = 7 Hz, 1H), 0.94 (d, J = 7 Hz, 6H); 13C NMR (75 
MHz, (CD3)2SO) δ 162.07, 161.71, 150.88, 129.26, 125.50, 113.50, 55.28, 40.71, 26.22, 22.19; 
IR (thin film) 1648, 1509 cm-1; HRMS (FAB+) calc’d for C13H18N2O2 ([M+H]+): 235.3, found 
235.3 ([M+H]+). 
2.5.2 4+2 Aza-Diels-Alder promoted by silane 2.1 
 
(S)-N-(4-oxo-2-phenyl-3,4-dihydropyridin-1(2H)-yl)benzamide: To a solution of (S,S)-
2.1  (151 mg, 0.481 mmol) in toluene (3 mL) was added hydrazone 2.2 (71 mg, 0.32 mmol).  The 
reaction mixture was stirred for 3 min and Danishefsky’s diene  (110 mg, 0.638 mmol) was 
added.   After 15 min, the reaction mixture was quenched by the addition of 1N HCl (5 mL) and 
stirred for 5 min.  The resulting mixture was transferred to a separatory flask and extracted with 
ethyl acetate (3 X 5 mL).  The combined organic phases were dried over Na2SO4, filtered, and 
concentrated.  Purification of the residue by flash chromatography (2:3 hexanes: ethyl acetate) 
provided the product as a yellow oil (76 mg, 82%). The enantiomeric excess of the product was 
determined to be 89% by comparison to a sample of the racemate (see attached HPLC trace 
below). [α]22D = - 151.17° (c 2.0, CHCl3). 1H NMR (400 MHz, CDCl3) δ 8.26 (s, 1H),  7.39-
7.35 (m, 1H), 7.27-7.20 (m, 9 H), 7.16 (d, J= 8 Hz, 1H)  5.14-5.09 (overlap, 2H), 2.83 (dd, J= 2 
,15 Hz, 1H), 2.53 (ddd, J= 1, 3, 12 Hz, 1H). 13C NMR (75 MHz, CDCl3) δ 192.15, 167.28, 




(thin film) 3240, 3064, 3006, 1663, 1636, 1519 cm-1; HRMS (FAB+) calc’d for C18H16N2O2 
([M+H]+): 293.3, found 293.3 ([M+H]+). 
 
N-(2-(naphthalen-2-yl)-4-oxo-3,4-dihydropyridin-1(2H)-yl)-4 
(trifluoromethyl)benzamide: After reaction and workup as in the general procedure above, the 
title compound was isolated as an oil (85%).The enantiomeric excess of the product was 
determined to be 90% by comparison to a sample of the racemate (see attached HPLC trace 
below). [α]22D = - 151.20° (c 1.1, CHCl3). 1H NMR (400 MHz, CDCl3) δ 7.91 (br d, J= 8 Hz, 
1H)  7.87-7.78 (m, 4H), 7.55-7.50 (m, 5 H), 7.39 (br d, J= 8 Hz, 2H), 7.31 (d, J= 8 Hz, 1 H), 
5.44 (dd, 1H, J= 4, 11 Hz), 5.31 (d, 1H, J= 8 Hz),  3.08 (dd, J= 17, 17 Hz, 1H), 2.75 (dd, J= 4, 
13 Hz, 1H). 13C NMR (75 MHz, CDCl3) δ 191.96, 166.05, 156.64, 134.58, 134.45, 134.05 (q, J 
= 33 Hz), 133.39, 133.23, 129.43, 127.91, 127.78, 127.47, 127.37, 126.87, 126.83, 125.75 (q, J = 
3 Hz), 124.05, 123.24 (q, J = 271 Hz ), 102.92, 65.74, 44.89. IR (thin film) 3233, 3057, 3010, 








reaction and workup as in the general procedure above, the title compound was isolated as an oil 
(58%).The enantiomeric excess of the product was determined to be 87% by comparison to a 
sample of the racemate (see attached HPLC trace below).  [α]22D = -132.02° (c 2.1, CHCl3). 1H 
NMR (400 MHz, CDCl3) δ 8.29 (s, 1H),  7.92-7.90 (d, J =8 Hz, 1H), 7.87-7.84 (d, J =8 Hz, 1H), 
7.73-7.37 (m, 7 H), 7.24-7.20 (m, 2 H), 7.14-7.12 (overlap, 2 H), 6.05-5.99 (m, 1H), 5.35 (dd, J= 
1, 7 Hz, 1 H), 3.28 (m, 1H), 2.82 (br d, J= 17 Hz,1 H). 13C NMR (75 MHz, CDCl3) δ 192.00, 
167.47, 157.12, 134.11, 132.76, 132.26, 131.28, 130.66, 129.28, 128.49, 126.86, 126.00, 125.42, 
122,58, 102.06, 43.81. IR (thin film) 3236, 3067, 3007, 1641, 1575 cm-1; HRMS (FAB+) calc’d 




reaction and workup as in the general procedure above, the title compound was isolated as an oil 
(72%).The enantiomeric excess of the product was determined to be 89% by comparison to a 
sample of the racemate (see attached HPLC trace below). [α]22D = - 189.62° (c .8, CHCl3). 1H 
NMR (400 MHz, 350K, CDCl3) δ 8.25 (s, 1H),  7.52-7.34 (m, 6 H), 7.26-7.24 (overlap, 3 H), 
5.23-5.18 (overlap, 2 H), 2.91-2.81 (m, 1H), 2.65-2.57 (m, 1H). 13C NMR (75 MHz, CDCl3) δ 
191.66, 167.08, 157.01, 136.52, 132.64, 132.35, 131.16, 129.20, 128.81, 126.99, 122.85, 102.72, 
64.91, 44.72; IR (thin film) 3240, 3005, 1655, 1584 cm-1; HRMS (FAB+) calc’d for 







After reaction and workup as in the general procedure above, the title compound was isolated as 
an oil (77%).The enantiomeric excess of the product was determined to be 90% by comparison 
to a sample of the racemate (see attached HPLC trace below). [α]22D = - 205.57° (c 1.6, CHCl3). 
1H NMR (400 MHz, CDCl3) δ 8.50 (s, 1H),  7.62 (d, J =12 Hz, 2H), 7.51-7.47 (m, 3H), 7.41-
7.39 (m, 2 H), 7.35-7.31 (m, 2 H), 7.26 (d, J= 8 Hz, 1H) 5.33-5.28 (dd, J= 4, 10 Hz, 1H), 5.23-
5.21 (dd, J= 1, 8 Hz, 1 H), 2.89-2.81 (dd, J= 2, 17 Hz, 1H), 2.64-2.59 (dd, J= 17, 2, 1H). 13C 
NMR (75 MHz, CDCl3) δ 191.40, 167.08, 157.15, 141.59, 131.14 (q, J= 32 Hz), 131.09, 128.82, 
127.95, 127.00, 126.21 (q, J= 3 Hz), 123.71 (q, J= 271 Hz), 65.13, 44.74. IR (thin film) 3244,  





(trifluoromethyl)benzamide:  After reaction and workup as in the general procedure above, the 




determined to be 90% by comparison to a sample of the racemate (see attached HPLC trace 
below). [α]22D = - 150.64° (c 1.2, CHCl3). 1H NMR (400 MHz, 350K, CDCl3) δ 7.93 (br s, 1H),  
7.58 (d, 2H, J= 9 Hz), 7.44 (d, 2 H, J= 8 Hz), 7.24-7.22 (overlap, 2H), 5.20 (d, 1H, J= 8 Hz), 
5.15 (dd, 1H, J= 4, 10 Hz),  2.92 (dd, J= 6, 6 Hz, 1H), 2.61 (ddd, J= 1, 2, 10 Hz, 1H). 13C NMR 
(75 MHz, CDCl3) δ 192.35, 166.03, 160.03, 156.53, 134.80, 134.05 (q, J = 33 Hz), 128.99, 
128.81, 127.53, 125.77 (q, J = 3 Hz), 123.33 (q, J = 273 Hz), 64.90, 55.31, 44.88. IR (thin film) 





(trifluoromethyl)benzamide:  To a solution of silane 1  (1.34 g, 4.26 mmol) in dichloromethane 
(28 mL) was added hydrazone 3g (500 mg, 2.13 mmol). The reaction mixture was stirred for 3 
min and diene 2 (1.10 g, 6.39 mmol) was added. After 15 min, the reaction mixture was 
quenched by the addition of 1N HCl (10 mL) and stirred for 5 min.  The resulting mixture was 
transferred to a separatory flask and extracted with dichloromethane (3 X 20 mL).  The 
combined organic phases were dried over Na2SO4, filtered, and concentrated.  Purification of the 
residue by flash chromatography (2:3 hexanes: ethyl acetate) provided the product as a yellow oil 
(522 mg, 81% yield). The enantiomeric excess of the product was determined to be 92% by 
comparison to a sample of the racemate (see attached HPLC trace below).  [α]22D = +52.41° (c 




2H), 6.96 (d, J =9 Hz, 2H), 5.07 (d, J= 8 Hz, 1 H), 4.10-4.06 (m, 1H), 3.87 (s, 3H), 2.75 (dd, J= 
12, 5 Hz, 1H), 2.41 (dd, J= 5, 11 Hz, 1H), 1.65-1.50 (overlap, 3H), . 13C NMR (75 MHz, CDCl3) 
δ 192.71, 166.22, 163.18, 156.64, 129.28, 123.46, 114.17, 100.68, 59.18, 55.51, 41.87, 39.54, 
24.34, 23.74, 21.36. IR (thin film) 3234, 1657, 1606, 1579 cm-1; HRMS (FAB+) calc’d for 




2.5.3 Synthesis of casopitant   
 
N'-(4-fluoro-2-methylbenzylidene)-4-methoxybenzohydrazide: To a solution of 4-
Fluoro-2-methylbenzaldehyde (5.0g, 36 mmol) in ethanol (160 mL) was added 4-
methoxybenzhydrazide (5.5g, 33 mmol).  The reaction mixture was stirred for five hours and 
filtered.  The collected solids were washed with hexanes to provide a white solid (8.3g, 82 % 
yield).  1H NMR (400 MHz, CD3OD) δ 8.54 (s, 1H, NNCH), 8.01 (dd, J = 3.6, 6 Hz, 1 H, Ar-
H), 7.85-7.81 (m, 2H, Ar-H), 6.96-6.94 (m, 2H, Ar-H), 6.91-6.87 (overlap, 2H, Ar-H, ), 3.78 (s, 
3H, Ar-OCH3), 2.40 (s, 3H, Ar-CH3). 13C NMR (75 MHz, CD3OD) δ 166.80, 165.01 (d, J = 226 
Hz), 164.50, 147.35, 141.65, 130.68, 130.04,129.92, 126.01, 118.11 (d, J = 22 Hz), 114.97, 
114.73 (d, J = 22 Hz), 55.99, 19.31; IR (thin film) 3221, 3042, 1643 , 1606, 1257 cm-1; HRMS 







methoxybenzamide:  To a solution of (S,S)-2.1 (141 mg, 0.449 mmol) in dichloromethane (2.5 
mL) was added hydrazone 2.15 (86 mg, 0.30 mmol). The reaction mixture was stirred for 3 min 
and Danishefsky’s diene  (155 mg, 0.900 mmol) was added.  After 30 min, the reaction mixture 
was quenched by the addition of 1N HCl (2 mL) and stirred for 5 min.  The resulting mixture 
was transferred to a separatory flask and extracted with dichloromethane (3 X 10 mL).  The 
combined organic phases were dried over Na2SO4, filtered, and concentrated.  Purification of the 
residue via flash chromatography (2:3 hexanes: ethyl acetate) provided the product as a yellow 
oil (87 mg, 82% yield). The enantiomeric excess of the product was determined to be + 84% by 
comparison to a sample of the racemate (see attached HPLC trace below). [α]22D = + 184.9° (c 
1.4, CHCl3).  1H NMR (400 MHz, CD3OD) δ 7.55 (br s, 1H, N-H), 7.51 (dd, J = 6, 4 Hz, 1 H, 
Ar-H), 7.36-7.33 (m, 2H, Ar-H), 7.31 (d, J= 8 Hz, 1H, OCC=CH), 7.00 (ddt, J= 2, 3, 3 Hz, 1H, 
Ar-H ), 6.86-6.82 (overlap, 3H, Ar-H),  5.59 (dd, J = 5, 10 Hz, 1H, NCH-Ar), 5.28 (dd, J = 2, 7 
Hz, 1H, C=CHN). 3.81 (s, 3H, ), 2.88 (dd, J = 2, 15 Hz, 1 H, Ar-CCHHCO), 2.63 (ddd, J = 1, 3, 
10 Hz, 1 H, Ar-CCHHCO), 2.26 (s, 3H, Ar-CH3). 13C NMR (75 MHz, CDCl3) δ 192.40, 167.20, 
163.44, 162.41 (d, J = 246 Hz), 158.37, 139.48 (d, J = 8 Hz), 132.18, 129.40, 128.80 (d, J = 8 
Hz), 123.85, 118.15 (d, J = 21Hz), 114.44, 114.25 (d, J = 21Hz), 102.46, 61.41, 55.84, 44.96, 








methylphenyl)piperidin-1-yl)-4-methoxybenzamide:  To a glass liner equipped with a stir bar 
was added a solution of 2.16 (422 mg, 1.19 mmol)  in methanol (12 mL).  Subsequently, DIPEA 
(0.4 mL),  1-acetylpiperazine (305 mg, 2.38 mmol), 20% Pd(OH)2/C (42 mg) were added.   The 
glass liner was then placed into a Parr bomb, and the gas inlet/pressure gage assembly was 
screwed onto the bomb apparatus. The bomb was charged to 200 psi with H2 and slowly vented 
to 160 psi.  The bomb was then immersed in an oil bath and heated to 60 °C.  After 48 hours, the 
bomb was cooled to room temperature and vented.  The residue was diluted with methanol (15 
mL) and filtered through a pad of celite.  After concentration, the resulting viscous yellow oil 
was purified via flash chromotagraphy (1:9 MeOH: EtOAc to 3:7 MeOH: EtOAc) to afford a 
mixture of 2.20 and silica gel. EtOAc was added to this mixture and stirred for 10 min. 
Subsequent filtration, EtOAc wash, and concentration afforded 2.20 (300 mg, 54% yield of 
major diastereomer, 7.1:1 dr) as a yellow oil.  
2.5.4 Stereochemical proof 
Both diastereomers were analyzed by COSY and NOESY NMR, and the key nOe 
interactions were indicated for 7, establishing the relative stereochemistry of the piperzinyl-





 [α]22D = - 1.88° (c .4, CHCl3). 1H NMR (400 MHz, 350K, CD3OD) δ 7.60-7.56 (m, 1H, 
Ar-H), 7.27-7.23 (m, 2 H, Ar-H), 6.76-6.67 (overlap, 4H, Ar-H),  4.45 (br d, J = 9.6, 1H, Ar-
CHN), 3.68 (s, 3H, Ar-OCH3), 3.55-3.50 (m, 4H, CH2NCOCH2), 3.13-3.07 (m, 1 H, NNCHH), 
2.95-2.93 (m, 1H, NNCHH), 2.54-2.44 (m, 4 H, CH2NCH2), 2.32, (s, 3H, Ar-CH3), 2.25 (m, 1H, 
NCHCH2CH-Ar) 2.03-2.0 (overlap, 6 H, NCOCH3, NNCH2CHH, NNCH2CHH, Ar-CHCHH), 
1.64 (br t, J = 13Hz,  1 H, Ar-CHCHH). 13C NMR (75 MHz, CD3OD) δ 170.53, 167.52, 162.78, 
161.71 (d, J = 241.43 Hz), 137.60, 137.00, 128.96, 125.97, 116.17 (d, J = 21 Hz), 113.59, 112.58 
(d, J = 21 Hz), 58.81, 56.61, 54.83, 51.44, 50.50, 49.98, 47.73, 42.00, 36.96, 27.50, 20.06, 18.48. 
IR (thin film) 3228, 2958, 2923, 2860, 2361, 1629, 1500, 1450, 1248 cm-1; HRMS (FAB+) 




[α]22D = + 12.27° (c .3, CHCl3). 1H NMR (400 MHz, 350K, CD3OD) δ 7.53-7.50 (m, 1H, 
Ar-H), 7.24-7.21 (m, 2 H, Ar-H), 6.75-6.67 (overlap, 4H, Ar-H),  4.02 (br d, J =11 Hz, 1H, Ar-




NNCHH), 2.80 (br q, J= 5, 10 Hz, 1H, NNCHH), 2.54-2.48 (m, J= 5, 9 Hz, 4 H, CH2NCH2), 
2.31 (s, 3H, Ar-CH3), 1.98 (s, 3H, NCOCH3), 1.89-1.86 (overlap, 3 H, NNCH2CHH, 
NNCH2CHH, Ar-CHCHH),  1.53-1.50 (m, 1 H, Ar-CHCHH). 13C NMR (75 MHz, CD3OD) δ 
171.54, 168.65, 163.83, 162.80 (d, J = 242 Hz), 138.72, 137.48, 129.92, 126.93, 117.30 (d, J = 
21 Hz), 114.60, 113.62 (d, J = 21 Hz), 64.58, 62.77, 55.45, 55.83, 50.20, 50.07, 47.50, 42.72, 
37.70, 28.48, 21.03, 19.28. IR (thin film) 3429, 3235, 2918, 2812, 2371, 1621, 1498, 1419, 1242 




methylphenyl)-N-methylpiperidine-1-carboxamide: To a cooled (-78 °C) solution of 
piperidinone 2.20 (30 mg, 0.064 mmol) in degassed methanol (1 mL) was added a solution of 0.1 
M SmI2 in tetrahydrofuran (3.2 mL).  The resulting reaction mixture was warmed to ambient 
temperature for 20 min and quenched by exposure to air (~2 min).   The quenched reaction 
mixture was concentrated and diluted with EtOAc (5 mL) and 1 N NaOH (3 mL).  The mixture 
was poured into a separatory funnel and extracted with EtOAc (3 X 10 mL).  The combined 
organic phases were washed with brine (2 X 2 mL), dried over Na2SO4, filtered, and 
concentrated.  The viscous yellow oil was co-evaporated with dichloromethane (2 X 1 mL).   To 




cooled to 0 °C.  To the cooled solution, was added a solution of triphosgene (39 mg, 0.13 mmol) 
in dichloromethane (0.5 mL), and the resulting reaction mixture was allowed to warm to ambient 
temperature (15 min).  To the warmed mixture was added a solution of amine 2.12 (54 mg, 0.20 
mmol) in dichloromethane (0.5 mL). After 48 h at 50 °C, the mixture was quenched with sat 
NaHCO3 (2 mL) and extracted with dichloromethane (3 X 5 mL).  The combined organic phases 
were dried over Na2SO4, filtered, and concentrated.  Purification of the residue via flash 
chromatography (1:5:100 NEt3:EtOH:EtOAc) afforded Casopitant as an oil (23 mg, 58%, 11.6:1 
dr). [α]22D = -4.05° (c .3, CHCl3). 1H NMR (400 MHz, 350K, CDCl3) δ 7.78 (s, 1H, Ar-H), 7.58 
(s, 2 H, Ar-H), 7.15 (q, J =3, 6 Hz, 1H, Ar-H), 6.84 (dd, J =2, 7 Hz, 1H, Ar-H),  (ddd, J =2, 3, 6 
Hz, 1H, Ar-H),   5.56 (q, J =7 Hz, 1H, NCHCH3), 4.29 (dd, J = 3, 9 Hz, 1H, Ar-CHN), 3.64-
3.53 (m, 2 H, CH2OCNCH2), 3.44 (br t, J = 5 Hz, 2 H, CHHOCNCHH), 3.38-3.35 (m, 1H, 
OCNCHHCH2), 2.86 (dd, J = 2, 10 Hz, 1H, OCNCHHCH2), 2.73 (s, 1 H, NCH3), 2.58-2.50 
(overlap, 5 H, CH2NCH2, HCNCH2), 2.44 (s, 3H, NOCH3), 2.07 (s, 1 H, Ar-CH3), 2.00-1.93 
(overlap, 2 H, CHHCH-Ar, OCNCH2CHH), 1.64 (ddd, 1 H, OCNCH2CHH), 1.53-1.46 (m, 1 H, 
CHHCH-Ar), 1.43 (d, J = 7 Hz, 3 H).  13C NMR (75 MHz, CDCl3) δ 168.79, 165.39, 161.07 (d, 
J = 243 Hz), 143.75, 138.21, 136.03 (d, J = 243 Hz), 131.88 (q, J = 33 Hz), 127.08, 125.93 (d, J 
= 8 Hz), 123.16 (q, J = 272 Hz), 121.35, 117.10 (d, J = 21 Hz), 112.69 (d, J = 21 Hz), 61.47, 
56.35, 51.95, 49.41, 49.04, 48.61, 46.54, 41.63, 36.78, 29.70, 27.74, 21.23, 19.41, 15.49. IR (thin 
film) 2943, 2829, 2342, 1649, 1434, 1370, 1279, 1169, 1126 cm-1; HRMS (FAB+) calc’d for 






2.5.5 HPLC traces 
 












































































































































































Chapter 3: Aza-Diels-Alder Reactions with Non-Danishefsky Type Dienes 
3.1 Introduction 
Asymmeteric aza-Diels-Alder reactions with imines and unactivated or non-Danishefsky 
type dienes are powerful tools to efficiently access highly functionalized piperidines that are 
present in many biologically active natural products and drug targets.32  Although asymmetric 
aza-Diels-Alder reactions with Danshefsky’s diene have been investigated extensively, there are 
very few reported asymmetric aza-Diels-Alder reactions with unactivated dienes.33 To our 
knowledge, there are only two examples of asymmetric aza-Diels-Alder reactions of unactivated 
dienes.34  The Jørgensen group subjected hydrazone (3.1, Scheme 3.1) and cyclic conjugated 
dienes 3.2a,b to copper catalysts with a chiral phosphine ligand and was able to obtain moderate 
yields and enantioselectivities of 3.3.34a  However, when 2,3-dimethyl-1,3-butadiene was 
exposed to the copper catalyst and chiral ligand with hydrazone 3.1, low yields and 
enantioselectivites were observed, severely limiting the substrate scope of this reaction.  The 
Gautun group subjected optically active N-sulfinyl α-imino ester (3.5, Scheme 3.2) to dimethyl-
1,3-butadiene but was unable to separate the resulting diastereomers 3.6 and 3.7.34b  In addition, 
harsh acidic conditions with hydrogen chloride were required to obtain the free secondary amine.   
                                                 
32 a) Alvaro, G.; Di Fabio, R.; Maragni, P.; Tampieri, M.; Tranquillini, M. E.;  PCT Int.  Appl.  (2002), 
WO0232867. b) Mu, S. Z.; Wang, J. S.; Yang, X. S.; He, H. P.; Li, C. S.; Di, Y. T.; Wang, Y.; Zhang, Yu.; Fang, 
X.; Huang, L. J.; Hao, X. J. J. Nat. Prod. 2008, 71, 564-569. c) Lindsay, B.; Pyne, S. G.; J. Org.  Chem. 2002, 67, 
7774-7780. 
33 a) Kobayashi, S.; Mori, Y.; Fossey, J. S.; Salter, M.M. Chem. Rev., 2011, 111, 2626-2704 
34 a) Yao, S.; Saaby, S.; Hazell, R. G.; Jørgensen, K. A. Chem. Eur. J. 2000, 6, 2435-2448. b) Andreassen, 





Scheme 3.1 Jørgensen aza-Diels-Alder reactions with unactivated dienes 
 
Scheme 3.2 Gautun aza-Diels-Alder with unactivated dienes 
 
In order to address the serious limitations of aza-Diels-Alder reactions with un-activated 
dienes, we looked to previous studies with Danishefsky’s diene and Leighton’s neopentoxy 
silicon acid  [(R,R)-3.8, Scheme 3.3], which could facilitate aza-Diels-Alder reactions between 
3.9 and Danishefsky’s diene to yield 3.10 in high yields and enantioselectivities. We hoped to 
extend this method to aza-Diels-Alder reactions with non-Danishfesky type dienes and address 




Scheme 3.3 Aza-Diels-Alder reactions with silicon Lewis acid and non-Danishefesky 
type dienes 
 
3.2 Asymmetric silicon Lewis acid mediated aza-Diels-Alder reactions with non-
Danishefsky’s diene  
Initial studies by Dr. Uttam Tambar with cyclopentadiene and hydrazone (3.9, Scheme 3.4) 
began with silane (S,S)-3.8.  Unfortunately, he soon found the reaction stalled at fifteen minutes 
and decomposition was observed. Therefore, he looked to previous studies in which silane (R,R)-
3.11) could facilitate efficient [3+2] cycloadditions of electron rich olefins and glyoxylate 
hydrazones.35 Subjection of (R,R)-3.11 to similar conditions with cyclopentadiene and glyoxylate 
derived hydrazone 3.12 produced no [4+2] product but [3+2] product 3.13 was formed in 
excellent yield and enantioselectivity. In addition, during Dr. Tambar’s screen of non-
                                                 




Danishefsky type dienes, (R,R)-3.11 was treated with 2,3-dimethyl-1,3-butadiene and hydrazone 
(3.12, Scheme 3.5) and [3+2] product 3.14 and [4+2] product 3.15 was observed in a 1:1 ratio. 
We postulated this 1:1 ratio of [3+2]:[4+2] could result from diene attack of hydrazone (3.12, 
Scheme 3.6) and formation of an allyl cation intermediate 3.16. Subsequently, intramolecular 
cyclization could occur through pathway a or b generating 3.14 or 3.15 respectively. 





Scheme 3.5 Silicon mediated 2,3-dimethyl-1,3-butadiene cycloaddition 
 
Scheme 3.6 Mechanistic pathway for diene attack 
 
In order to improve selectivity for pathway b, Dr. Tambar reasoned electronic tuning of 
the hydrazone aryl group could provide a slightly better ratio of [4+2] product.  For example, 
when an electron withdrawing group was added to hydrazone (3.17, Scheme 3.7), a 1:1.5 ratio of 
products 3.18a:3.19a was obtained, indicating a slight preference for the [4+2] cyclization 
pathway.  When an electron-rich moiety was added, a 1.8:1 ratio of products 3.18b:3.19b was 




aryl portion of the hydrazone favored formation of [4+2] product 3.17c with a ratio of (1:1.8), 
implying sterics may play an important role.  
Scheme 3.7 Mechanistic investigation through electronic tuning of the hydrazone 
 
Therefore, Dr. Tambar examined the bulkier pivaloyl hydrazone (3.20, Scheme 3.8).  To 
our delight, the pivaloyl hydrazone 3.20 with (R,R)-3.11 and 2,3-dimethyl-1,3-butadiene formed 
exclusively 3.21 in 69% yield.  Further optimization using dichloromethane as a solvent gave 
91% yield and 85% ee of (3.21, Scheme 3.8). We reasoned that the steric bulk of the pivaloyl 
group on hydrazone (3.20, Scheme 3.9) could prevent cyclization through pathway a of complex 
3.16, and 3.21 could form exclusively through favored pathway b.  





Scheme 3.9  Regioselectivity due to the steric bulk of the pivalyl group 
 
With the problem of regioselectivity solved, the scope of this reaction was extended to 
include different alkyl- and aryl- substituted dienes with hydrazone (3.20, Table 3.1) to form 
3.22. When alkyl substituted dienes were subjected to the reaction conditions (Entries 1-3), near 
quantitative yields and good enantioselectivities were achieved.  As shown in Entry 4, a phenyl 
substituted diene was utilized but resulted in lower enantioselectivites.  In order to solve this 




Entry 5.  When an electron with-drawing para-bromine group (Entry 6) was added to the phenyl 
substituted diene, chloroform was found to give the best yields and selectivities.      
Table 3.1 Reaction scope with respect to the diene 
 
Entry R solvent yield (%) ee (%) 
1 Me CHCl3 96 85 
2 PhCH2CH2 CHCl3 99 87 
3 PMBOCH2CH2 CHCl3 95 90 
4* 
 
Ph CHCl3 99 -81 
5 Ph PhCH3 66 95 
6* p-BrC6H4 CHCl3 99 -86 
* (S,S)-3.11 was used 
Dr. Tambar also was able to expand the scope of this reaction to aliphatic hydrazone 
(3.23, Scheme 3.10).  Although higher temperatures and reaction times were needed, diene 3.24 
provided product 3.25 in nearly quantitative yield and excellent enantioselectivity.  In addition, 
diene 3.26 provided structurally interesting piperidinone product 3.27.  Phenylbutadiene (3.28a, 
Scheme 3.11) required longer reactions times but was able to provide product 3.29a in excellent 




higher boiling solvents and found dichloroethene to be the solvent of choice, which produced 
product 3.29b in good yield and enantioselectivities.  
Scheme 3.10 Substrate scope with respect to an aliphatic hydrazone  
 
Scheme 3.11 Optimization of an aliphatic hydrazone and phenylbutadiene 
 
In our efforts to further expand our reaction scope, we looked to dienes 3.30 and 3.31 
(Scheme 3.12).  Although these dienes have been utilized in many Diels-Alder reactions, the 
general scope of these dienes in aza-Diels-Alder reactions has not been previously examined.36   
Utilizing (R,R)-3.11, we subjected hydrazone 3.20 to dienes 3.30 and 3.31 and found complex 
                                                 
36 Yu, M.; Danishefsky, S. J. J. Am. Chem. Soc. 2008, 130, 2783-2785. (b) Hayden, A. E.; DeChancie, J.; George, 
A. H.; Dai, M.; Yu, M.; Danishefsky, S. J.; Houk, K. N. J. Org. Chem. 2009, 74, 6770-6776. (c) Henderson, J. R.; 




products 3.32 and 3.33 could be obtained in good enantioselectivity and reactivity.  We believe 
regioselectivity of this reaction is due to the formation of a more stable tertiary cation in the 
intial C-C bond forming step.  As shown in Scheme 3.13, vinyl indene 3.34 attacks silane-
hydrazone complex 3.35, generating complex 3.36.  The shown attack of the more hindered 
carbon as opposed to the terminal nucleophilic carbon on the diene explains the regioselectivity 
of this reaction.  
Scheme 3.12 Aza-Diels-Alder reactions with vinyl indene 
 
Scheme 3.13 Regioselectiviy of aza-Diels-Alder reactions with vinyl indenes 
 
Tetralone derived dienes 3.37 and 3.39 (Scheme 3.14) were also subjected to (R,R)-3.11 




Interestingly, we found a change in regioselectivity from the vinyl indene dienes had occurred.  
We believe this change in regioselectivity occurs to minimize steric interactions in the intial C-C 
bond forming event (Scheme 3.15).  The less sterically hindered nucleophilic carbon on tetralone 
3.41 forms the initial C-C bond with 3.35 to form 3.42.  
Scheme 3.14 Aza-Diels-Alder reactions with tetralone derived dienes 
 
Scheme 3.15 Steric effect of aza-Diels-Alder reactions with tetralone derived dienes 
 
We believed that subjecting glyoxylate 3.20 and (R,R)-3.11 to methoxy tetralone derived 




of the methoxy substitutent. As shown in Scheme 3.16, the resulting product 3.44 did in fact 
indicate a reversal of regioselectivity from products 3.38 and 3.40. This change in 
regioselectivity re-established electronic control of the tetralone derived dienes.  However, a low 
enantioselectivity of 62% was observed and further optimization was needed.  An initial solvent 
screen of polar solvents such as dichloromethane and non-polar solvents such as toluene did not 
result in a higher enantioselective reaction.  Therefore, we decided to change the hydrazone to a 
readily prepared ethyl glyoxylate derived hydrazone (3.45, Table 3.2).  Subjection of 3.45 to 3.43 
and (R,R)-3.11 in toluene resulted in 3.46 in low yield with good enantioselectivity, 
regioselectivity, and diastereoselectivity.  Higher yields were obtained in more polar solvents 
such as dichloromethane and trifluorotoluene. However, lower enantioselectivities were 
observed.  The use of benzene as a solvent greatly increased enantioselectivities, but 
regioselectivity and diastereoselectivity decreased.  Upon examination of Entries 1 and 4, we 
reasoned a mixture of benzene and toluene could lead to good yields as well as selectivity.  In 
fact, as shown in Scheme 3.17, benzene and toluene gave product 3.46 in good enantioselectivity 
and yield.   
Scheme 3.16 Aza-Diels-Alder reactions with methoxy tetralone derived diene and 





Table 3.2 Aza-Diels-Alder reactions with methoxy tetralone derived diene and ethyl 
glyoxylate derived hydrazone 
 
Entry Solvent rr dr yield ee 
1 PhCH3 9:1 9:1 40% 80% 
2 CH2Cl2 > 99:1 9:1 78% 39% 
3 PhCF3 > 99:1 7:1 65% 35% 
4 PhH 6:1 3:1 63% 77% 
 
Scheme 3.17 Optimized Aza-Diels-Alder reactions with methoxy tetralone derived 
diene and ethyl glyoxylate derived hydrazone 
 
As shown in Scheme 3.18, the regioselectivity occurs due to the electron donating nature 




the more sterically hindered nucleophilic carbon on 3.43 to form complex 3.48. The ability to 
change the regioselectivity of this aza-Diels-Alder reaction from a remote substituent on the 
diene was particularly interesting since it is without precedent in the long history of Diels-Alder 
reactions. 
Scheme 3.18 Electronic effect of methoxy derived tetralone. 
 
 In order to further prove the utility of our silicon Lewis acid mediated aza-Diels-Alder 
reactions, we set out to obtain the free amine from N-N bond cleavage.  Dr. Tambar found 
reductive cleavage of the N-N bond could be easily achieved through the Friestad procedure in 
which (3.29a, Scheme 3.19) was benzoylated to produce 3.49 and reductively cleaved with SmI2 
to produce free amine 3.50.37  Alternatively, methylation of the pivalamide nitrogen on (3.29a, 
Scheme 3.20) produced zwitterion 3.51 and subsequent reductive cleavage generated the 
methylated amine 3.52.   
Scheme 3.19 Cleavage of N-N bond 
 
                                                 




Scheme 3.20 Alternative strategy for N-N bond cleavage 
 
3.3 Conclusion 
In summary, we have developed a highly enantioselective aza-Diels-Alder reaction with 
non-Danishefsky type dienes and hydrazones facilitated by a silicon Lewis acid to generate 
biologically important heterocycles.  We were able to expand the scope of these aza-Diels-Alder 
reactions to include different alkyl- and aryl- substituted dienes.  In addition, aliphatic and 
glyoxylate derived hydrazones were subjected to non-Danishefsky type dienes and silicon Lewis 
acid, resulting in good yields and enantioselectivities of highly functionalized piperidine type 
products.  We showed for the first time in the long history of Diels-Alder reactions that a remote 
substituent on tetralone derived dienes could change the regioselectivity of a reaction.  Lastly, we 
were able to obtain free amine product after cleavage of the N-N bond, further proving the utility 
of this method.38   
3.4 Supporting Information 
General Information. All reactions were carried out under an atmosphere of nitrogen in 
flame-dried glassware with magnetic stirring unless otherwise indicated. Degassed solvents were 
purified by passage through an activated alumina column. (R,R)-3.11 or (S,S)-3.11 was prepared 
by the previously reported method.39 Gas chromatographic analyses were performed on a 
                                                 
38 Tambar, U. K.; Lee, S. K.; Leighton, J. L. J. Am. Chem. Soc. 2010, 132, 10248-10250. 




Hewlett-Packard 6890 Series Gas Chromatograph equipped with a capillary split-splitless inlet 
and flame ionization detector with electronic pneumatics control using a Supelco ß-Dex 120 (30 
m x 0.25 mm) capillary GLC column. 1H NMR spectra were recorded on a Bruker DPX-300 
(300 MHz) or a Bruker DPX-400 (400 MHz) spectrometer and are reported in ppm from CDCl3 
internal standard (7.26 ppm), C6D6 (7.16 ppm), or DMSO-d6 (2.50 ppm). Data are reported as 
follows: (bs= broad singlet, s = singlet, d = doublet, t = triplet, q = quartet, quin = quintet, sep = 
septet, m = multiplet, dd = doublet of doublets, ddd = doublet of doublet of doublets; coupling 
constant(s) in Hz; integration). Proton decoupled 13C NMR spectra were recorded on a Bruker 
DPX-300 (75 MHz) or a Bruker DPX-400 (400 MHz) spectrometer and are reported in ppm 
from CDCl3 internal standard (77.23 ppm), C6D6 (128.39 ppm), or DMSO-d6 (40.45 ppm). 
Infrared spectra were recorded on a Perkin Elmer Paragon 1000 FT-IR spectrometer. Optical 
rotations were recorded on a Jasco DIP-1000 digital polarimeter. 
 
3.4.1 General procedure for the preparation of hydrazone starting material 
 
To a cooled (0 °C) solution of diiso-propyl L-tartrate (2.50 mL, 12.0 mmol) in H2O (12 
mL) was added NaIO4 (3.34 g, 15.6 mmol). The resulting mixture was warmed to 23 °C and 
stirred for 2 h. The layers were separated, and the aqueous layer was extracted with EtOAc (4 x 




solution of the residue (1.55g) in 10 mL of EtOH was added pivaloyl hydrazide40 (1.11 g, 9.55 
mmol). The resulting suspension was vigorously stirred for 48 h at 70 °C (oil bath, external 
temperature). The reaction mixture was cooled to 23 °C and concentrated. The residue was 
treated with hexanes (100 mL). The resulting suspension was filtered with hexanes washes. The 
resulting solid was collected and dried to give hydrazone 3.20 (437 mg) as a white solid. The 
filtrate was concentrated and resuspended in hexanes (100 mL). The resulting suspension was 
filtered with hexanes washing. The resulting solid was collected and dried to yield the product 
3.20 (812 mg) as a white solid. This process was repeated once more with the filtrate to yield the 
product 3.20  (579 mg) as a white solid. The three samples of white solid were combined to give 
1.83 g (89% yield) of 2e as a white solid. 1H NMR (300 MHz, DMSO-d6) δ 11.26 (s, 1H), 7.76 
(s, 1H), 5.03 (sep, J = 6.1 Hz, 1H), 1.25 (d, J = 6.1 Hz, 6H), 1.18 (s, 9H); 13C NMR (75 MHz, 
DMSO-d6) δ 175.8, 163.6, 137.8, 69.2, 39.1, 27.7, 22.5; IR (thin film) 3254, 2983, 1716, 1680, 
15382 cm-1; HRMS for C10H19O3N2 (FAB+): calcd 215.1396 ([M+H]+), found 215.1410 
([M+H]+). 
 
To a solution of hydrocinnamaldehyde (440 µL, 3.00 mmol) in 2 mL of EtOH was added 
pivaloyl hydrazide (290 mg, 2.50 mmol). The resulting suspension was vigorously stirred for 48 
h at 70 °C (oil bath, external temperature). The reaction mixture was cooled to 23 °C and 
concentrated. The residue was treated with hexanes (100 mL). The resulting suspension was 
                                                 
40 Ohmoto, K.; Yamamoto, T.; Okuma, M.; Horiuchi, T.; Imanishi, H.; Odagaki, Y.; Kawabata, K.; Sekioka. 




filtered with hexanes washes. The resulting solid was collected and dried to give 3.23 (370 mg, 
64% yield) as a white solid. 1H NMR (300 MHz, DMSO-d6) δ 10.46 (s, 1H), 7.67 (t, J = 5.1 Hz, 
1H), 7.32-7.17 (m, 5H), 2.78 (t, J = 7.6 Hz, 2H), 2.54-2.48 (m, 2H), 1.13 (s, 9H); 13C NMR (75 
MHz, DMSO-d6) δ 174.2, 150.8, 141.9, 129.3, 126.9, 38.5, 34.6, 33.0, 28.0; IR (thin film) 2961, 
2973, 1657, 1545 cm-1; HRMS for C14H21ON2 (FAB+): calcd 233.1654 ([M+H]+), found 
233.1653 ([M+H]+). 
 
3.4.2 General procedure for the preparation of dienes 
 
2,3-Dimethyl-1,3-butadiene and isoprene were purchased from Sigma-Aldrich and used as 
received. Diene 3.24 was prepared according to literature procedures.41 Dienes (Table 3.1, 
Entry 2, 3, 6, 3.26, 3.28a,b) were prepared by cross metathesis of the corresponding terminal 
alkynes with ethylene according to the procedure of Mori.42 
                                                 
41 Yeh, M.-C. P.; Hwu, C.-C. J. Organomet. Chem. 1991, 419, 341-355. 




Dienes 3.30 and 3.31 were prepared according to the procedure of Quin.43 Dienes 3.37 and 
3.43 were prepared according to the procedure of Pal.44 Diene 3.39 (Dane’s diene) was prepared 
according to the procedure of Knochel.45 
3.4.3 Procedure for enantioselective (formal) aza-Diels-Alder reactions 
 
To a solution of the indicated hydrazone (1.0 equiv) in the indicated solvent (7.5 mL/mmol 
of hydrazone) is added (R,R)-3.20 (1.5 equiv). After 5 min, the diene (2.0 equiv) is added, and 
the resulting mixture is stirred at the indicated temperature for the indicated time. The reaction is 
quenched by the addition of H2O (~20 mL/mmol of hydrazone) and the resulting mixture is 
vigorously stirred for 15 min. The layers are separated, and the aqueous layer is extracted with 
EtOAc (4 x 10 mL/mmol of hydrazone). The combined organic layers are dried over Na2SO4, 
                                                 
43 Quin, D. L.; Hughes, N. A.; Lawson, F.; Good, A. Tetrahedron 1983, 39, 401-407. 
44 Pal, K. Synthesis 1995, 1485-1487. 




filtered and concentrated. Purification of the residue by flash chromatography on silica gel 
affords the product. 
 
(R)-isopropyl 4,5-dimethyl-1-pivalamido-1,2,3,6-tetrahydropyridine-2-carboxylate: 
This reaction was performed according to the general procedure (0.30 mmol of 3.20 in CH2Cl2 at 
23 °C for 23 h), and purification by flash chromatography (2:1 hexanes:EtOAc) afforded the 
product (81 mg, 91% yield) as a white solid. The enantiomeric excess was determined to be 85% 
by chiral GC (see GC trace below). [α]22D = +15.0° (c 6.41, CHCl3); 1H NMR (300 MHz, 
CDCl3) δ 7.72 (s, 1H), 5.00 (sep, J = 6.3 Hz, 1H), 3.77 (dd, J = 3.3 Hz, 6.0 Hz, 1H), 3.40 (d, J = 
15.0 Hz, 1H), 3.31 (d, J = 15.0 Hz, 1H), 2.61 (d, J = 16.5 Hz, 1H), 2.32 (d, J = 16.5 Hz, 1H), 
1.55 (s, 3H), 1.48 (s, 3H), 1.20 (d, J = 6.3 Hz, 3H), 1.64 (d, J = 6.3 Hz, 3H), 1.13 (s, 9H); 13C 
NMR (75 MHz, CDCl3) δ 176.0, 172.6, 123.1, 122.3, 68.5, 61.1, 55.4, 38.2, 34.2, 27.5, 21.9, 
18.2, 16.3; IR (thin film): 3271, 2978, 1730, 1667, 1207, 1107 cm-1; HRMS (FAB+) calcd for 
C16H29O3N2: 297.2178 ([M+H]+), found 297.2177 ([M+H]+). 
 
(R)-isopropyl 4-methyl-1-pivalamido-1,2,3,6-tetrahydropyridine-2-carboxylate: This 
reaction was performed according to the general procedure (0.26 mmol of 3.20 in CHCl3 at 23 
°C for 24 h), and purification by flash chromatography (2:1 hexanes:EtOAc) afforded Entry 1, 
Table 3.1 (69 mg, 96% yield) as a white solid. [α]23D = +26.8° (c 2.65, CHCl3); 1H NMR (300 




Hz, 1H), 3.57 (d, J = 15.0 Hz, 1H), 3.43 (d, J = 15.3 Hz, 1H) 2.68 (d, J = 16.8 Hz, 1H), 2.36 (d, J 
= 17.1 Hz, 1H), 1.65 (s, 3H), 1.24 (d, J = 6.6 Hz, 3H), 1.21 (d, J = 6.3 Hz, 3H), 1.16 (s, 9H); 13C 
NMR (75 MHz, CDCl3) δ 176.1, 172.5, 130.5, 118.5, 68.7, 60.8, 50.8, 38.3, 33.2, 27.6, 23.0, 
22.0; IR (thin film) 3272, 2976, 1729, 1665, 1206, 1108 cm-1; HRMS (FAB+) calcd for 
C15H27O3N2: 283.2022 ([M+H]+), found 283.2031 ([M+H]+). 
 
(R)-N-(6-(((tert-butyldiphenylsilyl)oxy)methyl)-4-methyl-5,6-dihydropyridin-1(2H)-
yl)pivalamide.  In order to determine the enantiomeric excess of Entry 1, Table 3.1, it proved 
necessary to derivatize it: To a cooled (0 °C) solution of Entry 1, Table 3.1 (24 mg, 0.080 
mmol) in THF (1 mL) was added lithium aluminum hydride (15 mg, 0.40 mmol). After 25 min, 
the reaction mixture was quenched by the addition of H2O (15 µL), 15% aqueous NaOH (15 µL), 
and H2O (45 µL). The slurry was warmed to room temperature and stirred for 30 min, passed 
through a short pad of Celite (Et2O eluent), and concentrated. To a solution of the residue in 
CH2Cl2 (1 mL) was added DMAP (10 mg, 0.083 mmol), imidazole (17 mg, 0.25 mmol), and 
TBDPSCl (43 µL, 0.17 mmol). After 2.5 h, the reaction mixture was quenched by the addition of 
H2O (2 mL). The layers were separated, and the aqueous layer was extracted with CH2Cl2 (3 x 3 
mL). The combined organic layers were dried over Na2SO4, filtered, and concentrated. 
Purification of the residue by flash chromatography (5:1 hexanes:EtOAc) afforded the silyl ether 
(7.7 mg, 20% yield). The enantiomeric excess of the product was determined to be 85% by 
comparison to a sample of the racemate (see HPLC trace below). [α]24D = +15.1° (c  0.63, 




(s, 1H), 3.98 (dd, J = 5.4 Hz, 10.2 Hz, 1H), 3.54 (dd, J = 6.8 Hz, 10.4 Hz, 1H), 3.47-3.25 (m, 
2H), 2.27 (d, J = 18.0 Hz, 1H), 2.00 (dd, J = 7.7 Hz, 17.9 Hz, 1H), 1.69 (s, 3H), 1.07 (s, 9H), 
1.02 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 176.2, 135.8, 133.7, 132.4, 130.0, 128.0, 117.8, 65.6, 
60.2, 53.6, 38.3, 32.7, 27.6, 27.2, 23.2, 19.5;  IR (thin film) 3262, 2930, 1652, 1427, 1112 cm-1; 
HRMS (FAB+) calcd for C28H41O2N2Si: 465.2937 ([M+H]+), found 465.2947 ([M+H]+). 
 
(R)-isopropyl 4-phenethyl-1-pivalamido-1,2,3,6-tetrahydropyridine-2-carboxylate: 
This reaction was performed according to the general procedure (0.24 mmol of 3.20 in CHCl3 at 
23 °C for 24 h), and purification by flash chromatography (2:1 hexanes:EtOAc) afforded Entry 
2, Table 3.1 (69 mg, 99% yield) as a white solid. The enantiomeric excess of the product was 
determined to be 87% by comparison to a sample of the racemate (see HPLC trace below). 
[α]25D = +12.9° (c 7.88, CHCl3); 1H NMR (300 MHz, CDCl3) δ 7.79 (s, 1H), 7.28-7.14 (m, 5H), 
5.33 (s, 1H), 5.06 (sep, J = 6.3 Hz, 1H), 3.88 (dd, J = 3.0 Hz, 5.7 Hz, 1H), 3.62 (d, J = 15.6 Hz, 
1H), 3.47 (d, J = 15.6 Hz, 1H), 2.76-2.60 (m, 3H), 2.49 (d, J = 17.1 Hz, 1H), 2.25 (t, J = 8.0 Hz, 
2H), 1.25 (d, J = 6.6 Hz, 3H), 1.23 (d, J = 6.6 Hz, 3H), 1.18 (s, 9H); 13C NMR (75 MHz, CDCl3) 
δ 176.1, 172.5, 141.9, 133.8, 128.5, 128.4, 126.0, 118.6, 68.7, 60.7, 50.8, 38.7, 38.3, 34.1, 31.7, 
27.6, 22.0; IR (thin film) 3370, 2978, 1730, 1672, 1204, 1107 cm-1; HRMS (FAB+) calcd for 






tetrahydropyridine-2-carboxylate: This reaction was performed according to the general 
procedure (0.26 mmol of 3.20 in CHCl3 at 23 °C for 24 h), and purification by flash 
chromatography (1:1 hexanes:EtOAc) afforded Entry 3, Table 3.1 (58 mg, 95% yield) as a 
white solid. The enantiomeric excess of the product was determined to be 90% by comparison to 
a sample of the racemate (see HPLC trace below). [α]23D = +16.1° (c 3.09, CHCl3); 1H NMR 
(300 MHz, CDCl3) δ 7.76 (s, 1H), 7.23 (d, J = 8.7 Hz, 2H), 6.86 (d, J = 8.4 Hz, 2H), 5.36 (s, 
1H), 5.03 (sep, J = 6.3 Hz, 1H), 4.41 (s, 2H), 3.85 (dd, J = 3.0 Hz, 6.0 Hz, 1H), 3.79 (s, 3H), 3.61 
(d, J = 15.3 Hz, 1H), 3.50-3.45 (m, 3H), 2.72 (d, J = 17.1 Hz, 1H), 2.45 (d, J = 17.1 Hz, 1H), 
2.27 (t, J = 6.6 Hz, 2H), 1.23 (d, J = 6.3 Hz, 3H), 1.22 (d, J = 4.5 Hz, 3H), 1.18 (s, 9H); 13C 
NMR (75 MHz, CDCl3) δ 176.1, 172.5, 131.6, 130.6, 129.4, 128.5, 119.9, 113.9, 72.8, 68.7, 
68.6, 60.7, 55.4, 50.9, 38.3, 37.1, 31.9, 27.6, 22.0; IR (thin film) 2959, 1724, 1672, 1513, 1247, 
1105 cm-1; HRMS (FAB+) calcd for C24H37O5N2: 433.2702 ([M+H]+), found 433.2693 
([M+H]+). 
 
(S)-isopropyl 4-phenyl-1-pivalamido-1,2,3,6-tetrahydropyridine-2-carboxylate: This 
reaction was performed according to the general procedure (0.19 mmol of 3.20 in CHCl3 at 23 
°C for 24 h) except that (S,S)-3.11 was used, and purification by flash chromatography (3:1 
hexanes:EtOAc) afforded Entry 4, Table 3.1 (64 mg, 99% yield) as a white solid. The 
enantiomeric excess of the product was determined to be 81% by comparison to a sample of the 
racemate (see HPLC trace below). [α]20D = -4.7° (c 5.62, CHCl3); 1H NMR (300 MHz, CDCl3) δ 




Hz, 5.8 Hz, 1H), 3.89-3.79 (m, 1H), 3.61-3.63 (m, 1H), 3.17-3.05 (m, 1H), 3.03-2.92 (m, 1H), 
1.26 (d, J = 6.2 Hz, 3H), 1.21 (s, 9H), 1.19 (d, J = 6.4 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 
176.3, 172.4, 140.7, 133.7, 128.5, 128.5, 127.5, 125.4, 121.2, 69.0, 60.9, 51.3, 38.4, 31.2, 27.6, 
22.0, 21.9; IR (thin film): 2978, 1728, 1665 cm-1; HRMS (FAB+) calcd for C20H28O3N2: 
345.4479 ([M+H]+), found 345.2185 ([M+H]+). 
 
(R)-isopropyl 4-phenyl-1-pivalamido-1,2,3,6-tetrahydropyridine-2-carboxylate: This 
reaction was performed according to the general procedure (0.28 mmol of 3.20 in toluene at 23 
°C for 24 h), and purification by flash chromatography (3:1 hexanes:EtOAc) afforded Table 3.1, 
Entry 5 (63 mg, 66% yield) as a white solid. The enantiomeric excess of the product was 
determined to be 95% by comparison to a sample of the racemate (see HPLC trace below). 
 
(S)-isopropyl 4-(4-bromophenyl)-1-pivalamido-1,2,3,6-tetrahydropyridine-2-
carboxylate:  This reaction was performed according to the general procedure (0.26 mmol of 
3.20 in CHCl3 at 23 °C for 24 h) except that (S,S)-3.11 was used, and purification by flash 
chromatography (3:1 hexanes:EtOAc) afforded Entry 6, Table 3.1 (90 mg, 99% yield) as a 
white solid. The enantiomeric excess of the product was determined to be 86% by comparison to 
a sample of the racemate (see HPLC trace below). [α]20D = -41. 5° (c 0.91, CHCl3); 1H NMR 
(300 MHz, CDCl3) δ 7.89 (s, 1H), 7.43 (d, J = 8.4 Hz, 2H), 7.19 (d, J = 8.4 Hz, 2H), 5.90 (s, 




(d, J = 16.8 Hz, 1H), 3.10 (d, J = 16.5 Hz, 1H), 2.93 (d, J = 16.8 Hz, 1H), 1.26 (d, J = 6.3 Hz, 
3H), 1.22 (s, 9H), 1.19 (d, J = 6.0 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 176.4, 172.3, 139.6, 
132.8, 131.7, 127.1, 121.9, 121.5, 69.1, 60.8, 51.2, 38.4, 31.1, 27.7, 22.1; IR (thin film): 2978, 
1731, 1666, 1491, 1205, 1107 cm-1; HRMS (FAB+) calcd for C20H28BrO3N2: 423.1283 
([M+H]+), found 423.1270 ([M+H]+). 
 
Large scale reaction of Table 3.1, Entry 6: To a solution of hydrazone 3.20 (820 mg, 
3.83 mmol) in CHCl3 (38 mL) was added silane (R,R)-3.11 (1.51 g, 4.98 mmol, 1.3 equiv). After 
5 min, the diene (1.60 g, 7.65 mmol, 2.0 equiv) was added, and the resulting mixture was stirred 
at room temperature for 24 h. The reaction was quenched by the addition of H2O (15 mL), and 
the resulting mixture was stirred for 15 min. The layers were separated, and the aqueous layer 
was extracted with EtOAc (25 mL x 3). The combined organic fractions were dried over Na2SO4, 
filtered and concentrated under reduced pressure. Purification of the residue by flash 
chromatography (3:1 hexanes:EtOAc) on silica gel afforded ent-Table 3.1, Entry 6 as a white 
solid. The solid was treated with 20 mL of EtOH and the mixture was heated to reflux until all of 
the solid dissolved. The solution was cooled to room temperature and the resulting crystalline 
solid was collected and dried to give 1.13 g (70% yield) of ent-Table 3.1, Entry 6. The 
enantiomeric excess of the product was determined to be 98% by comparison to a sample of the 
racemate (see HPLC trace below). The aqueous phase from the above workup procedure was 
basified with 1M NaOH (15.0 mL) and extracted with EtOAc (3 X 50 mL). The combined 
organic layers were dried over anhydrous Na2SO4, filtered and concentrated to afford 765 mg 






yl)pivalamide: This reaction was performed according to the general procedure (0.17 mmol of 
3.23 in CHCl3 heated at reflux for 48 h) except that (S,S)-3.11 was used, and purification by flash 
chromatography (3:1 hexanes:EtOAc) afforded 3.27 (64 mg, 99% yield) as an oil. The 
enantiomeric excess of the product was determined to be 90% by comparison to a sample of the 
racemate (see HPLC trace below). [α]25D = +4.1° (c 5.64, CHCl3); 1H NMR (300 MHz, CDCl3) 
δ 7.30-7.18 (m, 5H) 6.72 (s, 1H), 5.15 (s, 1H), 3.68 (d, J = 17.0 Hz, 1H), 3.36 (d, J = 17.0 Hz, 
1H), 3.09-3.00 (m, 1H), 2.93-2.70 (m, 2H), 1.95 (d, J = 5.4 Hz, 2H), 1.89-1.77 (m, 1H), 1.63-
1.51 (m, 1H), 1.50 (d, J = 5.4 Hz, 2H), 1.22 (s, 9H), 0.06 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 
176.4, 142.6, 134.6, 128.7, 128.4, 125.8, 114.9, 58.3, 54.8, 38.5, 35.0, 32.6, 32.3, 27.8, 27.7, -
0.9, -1.0; IR (thin film) 3261, 2955, 1648, 1537, 1245, 848, 690 cm-1; HRMS (FAB+) calcd for 
C22H37ON2Si: 373.2675 ([M+H]+), found 373.2664 ([M+H]+). 
 
(S)-N-(4-oxo-2-phenethylpiperidin-1-yl)pivalamide: This reaction was performed 
according to the general procedure (0.22 mmol of 3.23 in CH2Cl2 heated at reflux for 24 h) 
except that the reaction was quenched by the addition of 1.0 M HCl instead of H2O, and 
purification by flash chromatography (3:1 hexanes:EtOAc) afforded 3.25 (51 mg, 78% yield) as 
a white solid. The enantiomeric excess of the product was determined to be 87% by comparison 
to a sample of the racemate (see HPLC trace below). [α]25D = +38.0° (c 1.55, CHCl3); 1H NMR 
(300 MHz, CDCl3) δ 7.29-7.13 (m, 5H), 6.58 (s, 1H), 3.35-3.18 (m, 3H), 2.80-2.68 (m, 2H), 




MHz, CDCl3) δ 207.5, 176.9, 141.7, 128.7, 128.5, 126.2, 61.5, 53.9, 45.3, 40.6, 38.6, 34.9, 30.9, 
27.8; IR (thin film) 3286, 2962, 1721, 1652, 1533 cm-1; HRMS (FAB+) calcd for C18H27O2N2: 
303.2073 ([M+H]+), found 303.2067 ([M+H]+). 
 
(S)-N-(6-phenethyl-4-phenyl-5,6-dihydropyridin-1(2H)-yl)pivalamide: This reaction 
was performed according to the general procedure (0.86 mmol of 3.23 in CHCl3 heated at reflux 
for 7 days), and purification by flash chromatography (3:1 hexanes:EtOAc) afforded 3.29a (257 
mg, 82% yield) a white solid. The enantiomeric excess of the product was determined to be 84% 
by comparison to a sample of the racemate (see HPLC trace below). [α]25D = +9.76° (c = 5.16, 
CHCl3); 1H NMR (300 MHz, CDCl3) δ 7.47-7.22 (m, 10H), 6.78 (s, 1H), 6.07 (s, 1H), 3.87 (d, J 
= 17.4 Hz, 1H), 3.64 (d, J = 13.8 Hz, 1H), 3.30-3.21 (m, 1H), 2.97-2.81 (m, 2H), 2.63-2.42 (m, 
2H), 2.04-1.92 (m, 1H), 1.81-1.71 (m, 1H), 1.25 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 176.5, 
142.5, 140.3, 135.1, 128.6, 128.5, 127.7, 125.9, 125.1, 120.2, 58.3, 55.1, 38.6, 34.7, 32.1, 29.7, 
27.8; IR (thin film): 3267, 2957, 1649, 1536, 1495 cm-1; HRMS (FAB+) calcd for C24H31ON2: 
363.2436 ([M+H]+), found 363.2445 ([M+H]+). 
 
(S)-N-(4-(4-methoxyphenyl)-6-phenethyl-5,6-dihydropyridin-1(2H)-yl)pivalamide): 
This reaction was performed according to the general procedure (0.29 mmol of 3.23 in 1,2-
dichloroethane heated at reflux for 12 h), and purification by flash chromatography (8:1 
hexanes:EtOAc) afforded 3.29b (60 mg, 54% yield) a white solid. The enantiomeric excess of 
the product was determined to be 87% by comparison to a sample of the racemate (see HPLC 




6.90-6.87 (m, 2H), 5.94 (bs, 1H), 3.81 (s, 3H) 3.81-3.77 (m, 1H), 3.60-3.53 (m, 1H), 3.20-3.13 
(m, 1H), 2.89-2.69 (m, 2 H), 2.25-2.29 (m, 1H), 2.42-2.38 (m, 1H), 1.98-1.86 (m, 1H), 1.75-1.63 
(m, 1H), 1.20 (s, 9 H); 13C NMR (75 MHz, CDCl3) δ 176.5, 159.3, 142.5, 134.4, 132.8, 128.6, 
128.5, 126.1, 125.8, 118.3, 113.9, 58.3, 55.4, 55.1, 38.6, 34.8, 32.1, 29.6, 27.8;  IR (thin film): 




carboxylate: This reaction was performed according to the general procedure (0.10 mmol of 
3.20 in PhCH3 at 23 °C for 24 h), and purification by flash chromatography (9:1 hexanes:EtOAc) 
afforded 3.32 (22 mg, 62% yield) as a white solid. The enantiomeric excess of the product was 
determined to be 83% by comparison to a sample of the racemate (see HPLC trace below). 
[α]19D = +36.8° (c 0.50, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.39-7.38 (m, 2H), 7.24-7.18 
(m, 3H), 5.90 (q, J = 3.0 Hz, 1H), 5.13 (sep, J = 6.0 Hz, 1H), 4.33 (d, J = 11.3 Hz, 1H), 4.31 (m, 
1H), 3.78 (dt, J = 16.8, 3.1 Hz, 1H), 3.27-3.24 (m, 1H), 2.92 (dd, J = 16.3, 8.1 Hz, 1H), 2.82 (dd, 
J = 16.3, 8.5 Hz, 1H), 1.33 (d, J = 6.2, 3H), 1.28 (d, J = 6.3, 3H), 1.16 (s, 9H); 13C NMR (75 
MHz, CDCl3) δ 177.9, 171.8, 144.0, 140.6, 140.0, 128.5, 127.3, 125.6, 120.8, 114.1, 68.9, 66.9, 
51.8, 45.6, 38.8, 34.5, 27.8, 22.3; IR (thin film) 2969, 1718, 1655 cm-1; LRMS (FAB+) calcd for 






c]pyridine-1-carboxylate: This reaction was performed according to the general procedure 
(0.10 mmol of 3.20 in CH2Cl2 at 23 °C for 24 h), and purification by flash chromatography (9:1 
hexanes:EtOAc) afforded 3.33 (29 mg, 66% yield) as a white solid. The enantiomeric excess of 
the product was determined to be 86% by comparison to a sample of the racemate (see HPLC 
trace below). [α]19D = -15.2° (c 0.30, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.41-7.25 (m, 4H), 
5.93 (q, J = 3.0 Hz, 1H), 5.15 (sep, J = 6.7 Hz, 1H), 4.35 (d, J = 10.0 Hz, 1H), 4.32 (m, 1H), 3.78 
(dt, J = 17.2, 3.0 Hz, 1H), 3.28-3.26 (m, 1H), 2.91 (dd, J = 16.3, 7.0 Hz, 1H), 2.82 (dd, J = 16.3, 
7.5 Hz, 1H), 1.35 (d, J = 6.1, 3H), 1.30 (d, J = 6.3, 3H), 1.18 (s, 9H); 13C NMR (75 MHz, 
(CD3)2CO) δ 177.7, 171.3, 147.3, 139.9, 139.7, 131.0, 129.5, 123.5, 122.1, 116.9, 68.9, 67.9, 
52.5, 46.3, 38.9, 34.1, 28.4, 22.8, 20.1; IR (thin film) 2358, 2336, 1713, 1668 cm-1; LRMS 
(FAB+) calcd for C21H27O3N2Br: 435.4 ([M+H]+), found 435.1 ([M+H]+). 
 
(3R,4aR)-isopropyl 4-pivalamido-2,3,4,4a,5,6-hexahydrobenzo[f]quinoline-3-
carboxylate: This reaction was performed according to the general procedure (0.23 mmol of 
3.20 in CH2Cl2 at 23 °C for 24 h), and purification by flash chromatography (4:1 
hexanes:EtOAc) afforded 3.38 (52 mg, 61% yield) as a white solid. (Two other products were 
also isolated in 16% and 21% yield, and were determined (by 1H NMR analysis) to be a 
diastereomer and regioisomer of 3.38 respectively. This allowed the determination that the 
reaction had proceeded with 4:1 diastereoselectivity (61:16) and 4:1 regioselectivity  (61+16 = 
77:21).) The enantiomeric excess of the product was determined to be 97% by comparison to a 




MHz, CDCl3) δ 7.57-7.53 (m, 1H), 7.26 (s, 1H), 7.18-7.14 (m, 2H), 7.12-7.08 (m, 1H), 6.25-6.23 
(m, 1H), 5.07 (sep, J = 6.3 Hz, 1H), 4.49 (d, J = 6.6 Hz, 1H), 4.29 (d, J = 6.6 Hz, 1H), 2.93-2.89 
(m, 2H), 2.73-2.63 (m, 1H), 2.56-2.46 (m, 1H), 2.38-2.30 (m, 1H), 1.79-1.65 (m, 1H), 1.28 (d, J 
= 6.3 Hz, 6H), 1.21 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 177.4, 172.2, 135.9, 134.9, 129.1, 
128.5, 127.5, 126.3, 124.1, 115.5, 68.7, 61.4, 38.8, 29.8, 28.7, 28.2, 27.7, 22.0, 21.9; IR (thin 
film) 2977, 2958, 1717, 1662, 1108 cm-1; HRMS (FAB+) calcd for C22H31O3N2: 371.2335 
([M+H]+), found 371.2313 ([M+H]+). 
 
(3R,4aR)-isopropyl 8-chloro-4-pivalamido-2,3,4,4a,5,6-hexahydrobenzo[f]quinoline-3-
carboxylate: This reaction was performed according to the general procedure (0.10 mmol of 
3.20 in CH2Cl2 at 23 °C for 12 h), and purification by flash chromatography (4:1 
hexanes:EtOAc) afforded 3.40 (23 mg, 57% yield) as a white solid. (Two other products were 
also isolated in 9% and 9% yield, and were determined (by 1H NMR analysis) to be a 
diastereomer and regioisomer of 3.40 respectively. This allowed the determination that the 
reaction had proceeded with 6:1 diastereoselectivity (57:9) and 7:1 regioselectivity  (57+9 = 
66:9).) The enantiomeric excess of the product was determined to be 95% by comparison to a 
sample of the racemate (see HPLC trace below). [α]19D = -136.1° (c 3.27, CHCl3); 1H NMR 
(400 MHz, CDCl3) δ 7.44 (d, J = 8.3 Hz, 1H), 7.1-7.0 (m, 2H), 6.18 (bs, 1H), 5.05 (q, J = 5.6 Hz, 
1H), 6.25-6.23 (m, 1H), 5.07 (sep, J = 6.3 Hz, 1H), 4.48 (bs, 1H), 4.27 (bs, 1H), 2.85-2.83 (m, 
2H), 2.67-2.60 (m, 1H), 2.51-2.46 (m, 1H), 2.32-2.29 (m, 1H), 1.70-1.64 (m, 1H), 1.26 (d, J = 
6.4 Hz, 6H), 1.18 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 177.5, 172.1, 137.4, 134.1, 133.0, 




(thin film) 2964, 2333, 2360 cm-1; LRMS (FAB+) calcd for C22H29O3N2Cl: 405.9 ([M+H]+), 
found 405.4 ([M+H]+). 
 
(4R,4aR)-ethyl 8-methoxy-3-pivalamido-2,3,4,4a,5,6-hexahydrobenzo[f]isoquinoline-
4-carboxylate: This reaction was performed according to the general procedure (0.10 mmol of 
3.45 in 1:1 PhCH3:PhH at 23 °C for 24 h), and purification by flash chromatography (4:1 
hexanes:EtOAc) afforded 3.46 (26 mg, 66% yield) as a white solid. (Two other products were 
also isolated in 7% and 10% yield, and were determined (by 1H NMR analysis) to be a 
diastereomer and regioisomer of 3.46 respectively. This allowed the determination that the 
reaction had proceeded with 9:1 diastereoselectivity (66:7) and 7:1 regioselectivity (66+7 = 
73:10).) The enantiomeric excess of the product was determined to be 77% by comparison to a 
sample of the racemate (see HPLC trace below). [α]19D = +10.6° (c  0.20, CHCl3); 1H NMR (300 
MHz, CDCl3) δ 7.49 (d, J = 10.5 Hz, 1H), 7.18 (s, 1H), 6.73 (dd, J = 8.9, 2.6 Hz, 1H), 6.60 (bd, J 
= 2.1 Hz, 1H), 4.30-4.16 (m, 3H), 4.05 (d, J = 9.0 Hz, 1H), 3.79 (s, 3H), 3.70-3.62 (m, 1H), 2.91-
2.78 (m, 3H), 1.94-1.83 (m, 1H), 1.64-1.53 (m, 1H), 1.32 (t, J = 7.2 Hz, 3H), 1.16 (s, 9H); 13C 
NMR (75 MHz, CDCl3) δ 177.5, 172.4, 159.3, 137.7, 132.7, 126.3, 125.4, 114.5, 113.5, 113.3, 
61.5, 55.6, 52.9, 39.7, 38.8, 29.9, 27.8, 27.3, 14.7, 1.4; IR (thin film) 2957, 2926, 2862, 2363, 





3.4.4 Cleavage of the N-N bond in the hydrazide products: 
 
To a cooled (0 °C) solution of 3.29a (79 mg, 0.22 mmol) in THF (2 mL) was added 
KHMDS (0.5 M in PhCH3, 0.87 mL, 0.44 mmol). After 15 min, BzCl (0.10 mL, 0.87 mmol) was 
added. The mixture was allowed to warm to room temperature and stirred for 15 h. The reaction 
was quenched by the addition of saturated aqueous NaHCO3 (5 mL). The layers were separated, 
and the aqueous layer was extracted with Et2O (3 x 5 mL). The combined organic layers were 
dried over Na2SO4, filtered, and concentrated. Purification of the residue by flash 
chromatography (10:1:0.2 hexanes:EtOAc:Et3N) afforded 90 mg of the benzoylated product 
(3.49) as a clear oil. A cooled (-78 °C) solution of the benzoylated product (90 mg, 0.19 mmol) 
in THF (2 mL) and MeOH (2 mL) was degassed for 30 min and then warmed to room 
temperature. SmI2 (6 mL of a 0.1 M solution in THF, 0.60 mmol) was added. After 40 min, the 
spetum was removed from the flask exposing the reaction mixture to air, and the mixture was 
stirred open to the air for 10 min. The mixture was treated with silica gel (2g), concentrated, and 
the resulting solid was dry-loaded directly onto a column. Purification by flash chromatography 
(100:5 hexanes:Et3N to 100:10:5 hexanes:EtOAc:Et3N to 100:20:5 hexanes:EtOAc:Et3N to 
50:50:5 hexanes:EtOAc:Et3N) provided 3.50 (32 mg, 56% yield for 2 steps). 1H NMR (300 
MHz, CDCl3) δ 7.42-7.20 (m, 10H), 6.15 (s, 1H), 3.61 (s, 2H), 2.91-2.79 (m, 3H), 2.53 (d, J = 
16.0 Hz, 1H), 2.31-2.22 (m, 1H), 1.89 (dd, J = 7.0, 15.0 Hz, 2H); 13C NMR (75 MHz, CDCl3) δ 
142.3, 141.6, 135.3, 128.6, 128.5, 127.2, 126.0, 125.1, 123.5, 52.8, 46.1, 38.7, 34.3, 32.6;  IR 
(thin film) 3027, 2920, 1659, 1492, 1445, cm-1; HRMS (FAB+) calcd for C19H22N: 264.1752 





To a cooled (0 °C) solution of 3.29a (43 mg, 0.12 mmol) in THF (2.5 mL) was added 
NHMDS (1.0 M in THF, 0.25 mL, 0.25 mmol). After 15 min, MeI (0.025 mL, 0.40 mmol) was 
added. The mixture was warmed to room temperature and stirred for 15 h. The reaction was 
quenched by the addition of water (5 mL). The layers were separated, and the aqueous layer was 
extracted with Et2O (3 x 5 mL). The combined organic layers were dried over Na2SO4, filtered, 
and concentrated. The residue was used in the next step without further purification, and was 
assigned structure 3.51 based on 1H NMR analysis, and on the fact that reduction with SmI2 
provided 3.52. A cooled (-78 °C) solution of the residue in THF (1 mL) and MeOH (1 mL) was 
degassed for 30 min and then warmed to room temperature. SmI2 (3.5 mL of a 0.1 M solution in 
THF, 0.35 mmol) was added. After 30 min, the spetum was removed from the flask exposing the 
reaction mixture to air, and the mixture was stirred open to the air for 10 min. The mixture was 
treated with silica gel (1 g), concentrated, and the resulting solid was dry-loaded directly onto a 
column. Purification by flash chromatography (100:5 hexanes:Et3N to 100:20:5 
hexanes:EtOAc:Et3N to 50:50:5 hexanes:EtOAc:Et3N) provided 3.52 (23 mg, 70% yield for 2 
steps). 1H NMR (300 MHz, CDCl3) δ 7.35-7.09 (m, 10H), 5.90 (s, 1H), 3.18 (d, J = 18.0 Hz, 
1H), 3.03 (dd, J = 2.7, 17.7 Hz, 1H), 2.73-2.25 (m, 3H), 2.20 (s, 3H), 1.90-1.55 (m, 4H); 13C 
NMR (75 MHz, CDCl3) δ 143.4, 142.0, 134.7, 129.1, 129.0, 128.9, 126.4, 125.7, 122.4, 58.1, 
57.9, 54.2, 40.3, 33.7, 32.8, 31.3; IR (thin film) 3021, 2926, 2771, 1492, 1451 cm-1; HRMS 




3.4.5 Relative and absolute stereochemistry of ADA products 
A sample of ent-Table 3.1, Entry 6  (prepared with (R,R)-3.11) was recrystallized from 
CH2Cl2/hexanes. The resulting colorless crystals were suitable for X-ray diffraction and the 
structure was solved (we thank Prof. Ged Parkin and Mr. Aaron Sattler for the x-ray structure 
analysis, and the National Science Foundation (CHE-0619638) is thanked for acquisition of an x-
ray diffractometer). This structure allowed the assignment of absolute configuration as shown. 
The absolute configuration of all other products was assigned by analogy.  
 
A sample of 3.38 was recrystallized from CH2Cl2/hexanes. The resulting colorless crystals 
were suitable for X-ray diffraction and the structure was solved (we thank Prof. Ged Parkin and 
Mr. Aaron Sattler for the x-ray structure analysis, and the National Science Foundation (CHE-
0619638) is thanked for acquisition of an x-ray diffractometer). This structure allowed the 
assignment of relative configuration as shown. The relative stereochemistry of 3.40 was assigned 





The relative stereochemistry of ADA products 3.32, 3.33, and 3.46 was assigned based on 














3.4.6 HPLC or GC traces 







Daicel Chiralpak AD-H, Hexane/i-PrOH = 98/2, 1.0 ml/min, 220 nm 
 






Daicel Chiralpak AD-H, Hexane/i-PrOH = 90/10, 1.0 ml/min, 254 nm 
 
 














Daicel Chiralpak AD-H, Hexane/EtOH = 98/2, 1.0 ml/min, 210 nm 
 
 






Daicel Chiralpak AD-H, Hexane/i-PrOH = 90/10, 1.0 ml/min, 254 nm 
 
 






Daicel Chiralpak AD-H, Hexane/i-PrOH = 90/10, 1.0 ml/min, 254 nm 
 
 






Daicel Chiralpak AD-H, Hexane/i-PrOH = 98/2, 1.0 ml/min, 254 nm 
 
 













3.4.7 1H NMR spectra 
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